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ABSTRACT: Bioprinting techniques have been flourishing in the field of biofabrication
with pronounced and exponential developments in the past years. Novel biomaterial inks
used for the formation of bioinks have been developed, allowing the manufacturing of in
vitro models and implants tested preclinically with a certain degree of success. Furthermore,
incredible advances in cell biology, namely, in pluripotent stem cells, have also contributed
to the latest milestones where more relevant tissues or organ-like constructs with a certain
degree of functionality can already be obtained. These incredible strides have been possible
with a multitude of multidisciplinary teams around the world, working to make bioprinted
tissues and organs more relevant and functional. Yet, there is still a long way to go until these biofabricated constructs will be able to
reach the clinics. In this review, we summarize the main bioprinting activities linking them to tissue and organ development and
physiology. Most bioprinting approaches focus on mimicking fully matured tissues. Future bioprinting strategies might pursue earlier
developmental stages of tissues and organs. The continuous convergence of the experts in the fields of material sciences, cell biology,
engineering, and many other disciplines will gradually allow us to overcome the barriers identified on the demanding path toward
manufacturing and adoption of tissue and organ replacements.
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1. INTRODUCTION
With the advent of tissue engineering and regenerative medicine
(TERM), new therapeutic approaches for the regeneration or
replacement of tissues and organs have been investigated over
the past decades.1−3
Biomaterials (naturally derived or synthetic)4−7 and suitable
stem cells8−10 hold great potential to be used to regenerate or
repair and, eventually, as a suitable replacement for tissues and
organs. Despite the increasing complexity of the tissue and organ
units developed so far, either generating acellular or cellular
constructs, an insufficient degree of functionality is achieved
when evaluated in vitro and ultimately in vivo. Novel approaches
aim to mimic to a certain extent the embryonically developed
counterparts but still fall short on the degree of complexity that
can be achieved.
All organs arise from the three germ layersectoderm,
endoderm, and mesodermthat we briefly discuss below to
guide the reader throughout the complexity of the different
tissues and organs. We will cover the spatiotemporal arrange-
ment and cellular organization of these layers, termed
gastrulation, and highlight their extreme complexity that is still
not totally understood. The complexity of several organs and
tissues is dictated not only by different specialized cells but also
by a complex and dynamic extracellular matrix (ECM)
composition. For example, in the case of the kidney, more
than 20 differentiated cell types are harbored to a complex ECM
composed of proteins, glycoproteins, and glycosaminoglycans
(GAGs). Stem cells could facilitate the generation of the
different cells required if properly maintained in culture and
expanded in a large scale. Both human embryonic and induced
pluripotent stem cells (iPSCs), in particular, have the potential
to fit this purpose. Pluripotent stem cells (PSCs) have an
indefinite self-renewal ability and plasticity, which allow in vitro
generation of an unlimited number of distinct cell types. PSCs
have thus opened new avenues for TERM.
In this review, we highlight the bioprinting of tissue and organ
units to achieve regenerative alternatives.We briefly describe the
most commonly used bioprinting techniques and biomaterials.
Furthermore, we cover the importance of understanding tissue
and organ development in order to obtain representative in vitro
models. This understanding can facilitate the development of
future approaches, which can help in building functional organ
units and pave the way for full organ bioprinting. After briefly
introducing PSCs, we present the general steps in embryonic
development and tissue morphogenesis. We elaborate on the
current state-of-the-art in tissue and organ bioprinting, with a
particular attention to the skin, nervous system, cartilage, bone,
blood vessels, heart, kidney, liver, pancreas, glands, cornea, and
muscle. In doing so, we will discuss the cell source used and the
maturity of the bioprinted constructs achieved.
Figure 1. Schematic representation of the steps necessary to produce bioprinted tissues and organ-like constructs.
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2. BIOPRINTING
Bioprinting is a group of additive manufacturing (AM)
technologies that allow the selective distribution of cells,
biomaterials, growth factors, or combinations thereof, to
manufacture living tissues and organs in three dimensions.11
Bioprinting encompasses the fabrication of both acellular
constructs characterized by hierarchical structural properties
or smart surface properties that can steer cell activity and cell-
laden biological constructs.11 For bioprinting, the process
workflow typically starts from the data acquisition of magnetic
resonance imaging (MRI) or computed tomography (CT) scans
of the affected tissue or organ to be manufactured (Figure 1).
These medical image data sets provide essential information
about the macrostructure of tissues and organs, but information
at themicrostructure or even at a cellular level is still not possible
with these techniques. Alternatively, advanced microscopy
(fluorescent, confocal, or two-photon) could provide further
detail at the cellular level; however, the structures that can be
imaged are normally limited in size, and primary tissue needs to
be sacrificed. Currently, MRI or CT data sets are mainly used to
design the overall volume to be manufactured, while the
information about the infill is normally designed through open-
source or proprietary bioprinter software. This is still a limiting
factor for more innovative bioprinting strategies, hence the true
power of the technology is yet to be unveiled.
Over the past decade, several bioprinting technologies have
been developed and adapted to manufacture tissues or organs by
selectively dispensing cells, hydrogels, or combinations of these.
These technologies are classified in several groups where the
nomenclature is normally associated with the mechanism
behind the bioprinting technique. The most predominant class
of bioprinting techniques is pressure-assisted systems, as these
are available at low costs. Other systems such as piezo-, thermal-,
laser-, acoustic, and microfluidic-driven bioprinting are less
popular due to their relatively higher cost. Here, we briefly
review these systems, while we refer readers to other recent
reviews for a more comprehensive report of bioprinting
technologies.12−21
Figure 2. Schematics of the bioprinting techniques commonly used to produce tissue and organ constructs: (a) pressure-assisted; (b) inkjet or droplet-
on-demand where droplets are formed by (c) thermal, (d) piezo, (e) electromagnetic, or (f) acoustic waves; (g) stereolithography; (h) laser-induced
forward transfer; and (i) microfluidic bioprinting. Adapted with permission from refs 12 and 24. Copyrights 2015 Elsevier Inc. and 2012 JohnWiley &
Sons, Ltd.
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2.1. Pressure-Assisted Bioprinting
Pressure-assisted systems are largely used among different
research groups working on bioprinting as more and more low-
cost systems are becoming commercially available.22,23 These
systems are normally equipped with one or more cartridges that
allow the dispensing of different combinations of cells and
biomaterials.23 Plastic or glass cartridges are filled with the
selected biomaterial inks or bioinks. By applying gas pressure,
the material is ejected in the form of a filament through a needle
or nozzle (Figure 2a). In this case, the type of material, the gas
pressure, nozzle diameter, and deposition speed normally define
the resolution. High resolution is difficult to achieve as the shear
stress increases with decreasing nozzle diameter, which usually
affects cell viability. The average strand diameter produced with
these systems varies from 200 μm to millimeter size.
2.2. Thermal-Assisted Bioprinting
The first bioprinting studies reported in the literature were
performed with thermal-assisted bioprinting where an office
inkjet printer was modified to allow the dispensing of cells and
biomaterials (Figure 2b,c).25,26 In this droplet-on-demand
(DOD) technology, an electrical element is used to generate
heat that vaporizes the material near the element, forming a
droplet (Figure 2c). This vaporization induces a sudden
expansion of the material in a small capillary channel, prompting
the formation and ejection of the droplet of material. The
application of heat influences cell viability during and post
bioprinting. Another disadvantage of this technique is the
limited range of viscosities that can be processed. Furthermore,
when cells are included, sedimentation and nozzle clogging are
also observed.27 The resolution of thermal bioprinting is
generally related to the volume ejected from each nozzle and
varies from the picoliter to nanoliter range, with a resolution as
low as 100 μm for bioprinted strands containing cells.
2.3. Piezo-Assisted Bioprinting
Piezoelectric materials normally change shape or size when
stimulated electrically. The piezo-assisted bioprinting technique
uses piezoelectric elements that upon deformation induce the
ejection of small volumes of materials in a droplet form (Figure
2d). Similar to thermal-assisted bioprinting, it is possible to
dispense droplets of picoliter to nanoliter volumes. With the
capability of dispensing very accurately nanoliter to picoliter
droplets, this bioprinting technique is normally used for the
fabrication of microarrays and similar screening platforms and
was used recently to deposit glia and retinal ganglion cells
without influencing cell viability.28 Other systems such as the
ones based on electromagnetic actuators have also been used for
bioprinting (Figure 2e). In these systems, the displacement of a
mechanical element induces the droplet formation, and this
element can be actuated in direct contact with the bioink or
indirectly with the deformation of an elastomeric membrane.
2.4. Acoustic Bioprinting
One of the few nozzle-free techniques is acoustic bioprinting,
where acoustic waves are applied to a liquid to generate the
ejection of a droplet (Figure 2f). This technique allows accurate
dispensing of individual cells encapsulated in picoliter
droplets.29 Acoustic waves or acoustic tweezers have been
used to organize cells accurately in specific configurations and
even deposit cells on top of previously positioned cells.30 The
speed of displacement is relatively slow, and further improve-
ments are necessary to position the large amounts of cells that
compose a tissue. Accurate control to position the cells might be
possible with acoustic wave technologies, but the application of
these to produce 3D constructs is yet to be achieved.
2.5. Magnetic-Assisted Bioprinting
The application of permanent magnets or Bitter electromagnets
to create magnetic fields has been extensively used for the
patterning of cells in controlled arrays or locations where the
magnetic field is stronger. For the control of the cells or cell
spheroids through the application of magnetic fields, a previous
labeling of cells withmagnetic nanoparticles or the application of
paramagnetic fluids is required. With magnetic-assisted
biofabrication assembly, it is already possible to create 3D
structures31 or single-cell patterning32 (according to the method
andmagnetic field used). As these technologies mature, a similar
approach could be envisioned by the combination of magnetic
fields to pattern cells during a bioprinting process or
postbioprinting. This is still not investigated, but it could open
the possibility to control cells throughout the bioprinting
process and even promote the possibility of post manufacturing
stimulation (e.g., by applying magnetic fields to control stem cell
fate33).
2.6. Light-Assisted Bioprinting
Some of the initial systems based on light-assisted bioprinting
are also termed as stereolithography (SLA). Within SLA
techniques, two distinctive types are used: laser or light source
systems such as digital light processing (DLP).12,34 The laser
systems induce selective cross-linking of a photosensitive
material point by point (Figure 2g), while DLP systems use a
dynamic mirror array that selectively projects light into areas to
cross-link all points assigned for each layer. Several other light-
based systems have been developed by, for instance, combining
pressure-based bioprinting with light-emitting diodes (LEDs)
that cross-link the material upon extrusion.35
Other laser-assisted bioprinting systems are used to selectively
dispense bioinks similar to DOD instead of selectively cross-
linking materials. These laser techniques are termed laser-
induced forward transfer (LIFT) where a fast-pulse laser beam is
focused on a point of a glass slide previously coated with an
absorbed layer that vaporizes and induces a droplet formation
(Figure 2h). The absorption layer also contains a layer of cell-
laden hydrogels.36 The bioink droplet that is formed is ejected
toward a collection glass slide previously coated with a hydrogel
layer to minimize impact. The bioprinted construct is formed by
the deposition of droplets with predesigned patterns layer-by-
layer until the 3D construct is obtained. Laser-assisted
bioprinting is another nozzle-free technique, which avoids
shear stress on cells normally observed in other techniques.
Two-photon polymerization (2PP) is also a light-assisted
bioprinting technique that allows a high-accuracy cross-linking
by selectively irradiating a voxel.37 2PP systems cross-link the
voxels of interest successively until a 3D structure is obtained.
Due to the high resolutions possible with 2PP, the build time is
rather long, and the size of the constructs normally obtained
ranges between a few hundreds of microns to a few millimeters.
2PP has been mainly used to produce 3D scaffolds that are
postseeded with cells, and only recent studies report cells
directly embedded in the resin.38
New SLA systems, also termed volumetric SLA, are capable of
cross-linking in a fast way a volume or 3D object by combining
the rotation of a resin vat and a DLP projector or laser light
source that selectively projects light in a synchronized way.39,40
This technique has been recently used to demonstrate the
capabilities of this new approach to produce bioprinted
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Figure 3. New material development and advanced strategies can lead to breakthroughs in bioprinting of complex organ and tissue constructs. (a)
Bioink development requires moving from hydrogels to bioinks with a number of requirements for successful organ formation. Gel in gel printing
techniques like (b) FRESH and (c) jammedmicrogels allow the free-form printing of softer gels into more complex structures. (d) New developments
in multitechnique hydrogels like thiol−ene gelatin expand the ink toolbox significantly. (e) Large-scale complex manufacturing of organ-like objects is
possible with advances in light-polymerization techniques. Adapted with permission for refs 51−53 and 55. Copyrights 2015 Hinton et al. (published
by The American Association for the Advancement of Science), 2018 Highley et al. (published by WILEY-VCH Verlag GmbH & Co. KGaA), 2019
Grigoryan et al. (published by The American Association for the Advancement of Science), and 2017 WILEY-VCH Verlag GmbH & Co. KGaA.
Table 1. Examples of Natural and Synthetic Polymers and Materials Used for Bioprinting
material class polymer/material common name techniques bioink use ref
Thermoplastic polymers
poly(esters) poly(caprolactone) PCL FDM, SLS N 69−71
poly(lactic acid) PLA FDM N 72
poly(lactic-co-glycolic acid) PLGA FDM N 73
poly(ethylene oxide terephthalate-co-butylene terephthalate) PEO/PBT FDM N 74
polyactive
poly(urethanes) thermoplastic poly(urethane) PU, TPU FDM N 75
Hydrogels
synthetic poly(ethylene oxide-co-propylene oxide) pluronic extrusion Y 76
poly(vinyl alcohol) PVA extrusion 77, 78
self-assembling peptides extrusion Y 79, 80
poly-N-isopropylacrylamide NIPAM extrusion, DLP Y 81
natural alginate extrusion, jet Y 82
hyaluronic acid HA extrusion, jet Y 83
decellularized extracellular matrix dECM extrusion Y 84
gelatin extrusion, DLP, jet Y 85
agarose Y/N 86, 87
nanocellulose Y 88
Resins
UV cross-linking poly(ester) acrylates DLP, 2PP, extrusion N 89
gelatin methacrylate GelMA 2PP, extrusion Y 90
poly(ethylene glycol) (meth)acrylate PEGDA, PEGMA 2PP, DLP, extrusion Y 91
poly(carbonate) acrylates 2PP, DLP N 92
Composites
composite additives nanocellulose extrusion Y 93
bioglass extrusion N 94
hydroxyapatite HAp extrusion/SLA Y 95
graphene oxide, reduced graphene oxide GO, rGO extrusion, DLP Y 96
carbon nanotubes extrusion Y 97
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constructs by including cells within the liquid resin that was
cross-linked with a total light exposure time below 1 min.39
While this technique allows a faster volume manufacturing, no
control of the cell spatial distribution can be achieved so far.
2.7. Microfluidics Bioprinting
Microfluidics is a long-established technology initiated in the
50’s41,42 that has been widely adopted by several fields, in
particular by TERM, where cells and biomaterials can be
cultured in highly defined and controlled conditions.43 The
possibility to control accurately fluid flow ensuring laminar
regimes has allowed researchers to investigate cellular environ-
ments with high accuracy while reducing the volume of reagents
necessary. Lately, bioprinting has adapted microfluidics chip
concepts as dispensing heads (Figure 2i). With this, it has been
possible to design new types of bioprinting systems that allow
accurate processing and dispensing of low viscosity materials
combinedwith cells.44−47 One of the advantages ofmicrofluidics
bioprinting is that it is based on well-established technology, and
the development of different heads is simple. Furthermore,
creating disposable microfluidic print heads is possible by
preparing the printing chambers with polydimethylsiloxane
(PDMS). Some commercially available bioprinters have already
adopted microfluidic dispensing technology.48,49
3. BIOMATERIALS, BIOMATERIAL INKS, AND BIOINKS
One of the initial limiting factors of bioprinting was the
availability of suitable biomaterials to be used as inks
(biomaterials only) or bioinks (biomaterials with cells).50
These biomaterials have to be selected, designed, and prepared
according to the chosen bioprinting technique and the target
tissue or organ (Figure 3a). New techniques including
supporting baths like FRESH51 and jammedmicrogels52 (Figure
3b and 3c) have expanded the printability of soft bioinks, while
broadly usable ink platforms53 (Figure 3d) expand the generality
of fabrication bioinks. Recent technological breakthroughs like
FRESH54 and SLATE55 (Figure 3e) allow the bioprinting of
complex organ-like structures. Numerous natural and synthetic
biomaterials, discussed below, have been explored. Despite the
large number of hydrogel formulations for bioprinting, it is still
difficult to generate the optimal material that is both printable
and capable of mimicking the cell microenvironment. Here, we
briefly summarize the most commonly used natural and
synthetic polymers, while we encourage the readers to refer to
recent exhaustive reports on materials for bioprinting.17,50,56−59
The materials used in bioprinting can be broken down into
thermoplastic polymers, hydrogels, light cross-linkable resins,
and composites (Table 1). While AM of thermoplastic polymers
and ultraviolet (UV) cross-linkable resins have a longer history
andmainly have been used to build scaffolds that are seeded with
cells post manufacturing, the bioprinting of hydrogels and
composites where cells are directly included in the manufactur-
ing process has a more recent emergence. Eachmaterial class has
separate requirements for the various 3D bioprinting techniques
(i.e., a gel for extrusion printing and a gel for DLP printing have
different requirements) and is beyond the scope of this review;
consequently, a brief overview of the classes of materials will be
given here. More comprehensive reviews can be found for
bioprinting materials, in general,13,14,60 for hydrogels61−63 and
composites.64 For technique-specific material requirements,
SLA,65 extrusion based bioprinting,66 selective laser sintering
(SLS),12,67 2PP,68 and inkjet or droplet-on-demand18,66 have
also been reviewed.
3.1. Thermoplastic Polymers
The application of hybrid approaches where hybrid AM/
bioprinting systems are used to manufacture a thermoplastic
scaffold in combination with less mechanically stable bioinks has
been explored for skeletal and in some cases organ
constructs.70,71,84 These scaffolds are manufactured utilizing
more classic methods of AM such as fused deposition modeling
(FDM) or SLS. In these multitechnique manufacturing systems,
the combination of both techniques is possible, although the
selection of thermoplastic polymers is limited to materials with
low melting temperatures. In general, most thermoplastic
polymers are melted at elevated temperature and extruded
through a nozzle, and upon cooling, chain entanglement and
polymer crystallization combine to create the 3D defined solid
polymer construct. Thermoplastic polymers for complex tissue
fabrication must perform both during fabrication [melting,
extrusion, solidification] and during tissue regeneration
[biocompatibility, degradation, tissue ingrowth]. Widely used
thermoplastic polymers for AM are limited to poly(esters),
poly(urethanes), and various copolymers based on these small
libraries.
Current materials-based research in this area focuses around
two main efforts. On one hand, the optimization of the
printability of commercial polymers,98 uniquely structured
copolymers, and blends can extend the application of currently
known polymer classes. On the other hand, the polymer library
is also being expanded into new backbones, like poly(ester
amides),99 to provide new classes of materials for thermoplastic
printing.
3.2. Hydrogels
The use of hydrogels in bioprinting, slow to make progress at
first, has emerged as an energetic area of research in the past five
years. Hydrogels are ideal materials for cell culture and
encapsulation, yet their softer mechanical properties and
hydrated state provide challenges for translation to high fidelity
printed constructs; this notable trade-off is well-known to the
community.62 The first uses of hydrogels in bioprinting were
agarose or collagen being used as a “3D paper” or support in
which to print 3D cell spheroids100,101 and poly(ethylene glycol)
(PEG) diacrylate (PEGDA) to print cell-encapsulated gels via
SLA.102 Currently, the Ca2+-induced gelation of alginate has
become one of the most widely used bioinks in 3D printing, with
photopolymerizable gels (resins, see below) like gelatin
methacrylate (GelMa) and PEGDA also being popular choices.
Despite these added challenges of fabricating with soft
materials, hydrogels provide an excellent scaffold for stimuli
responsiveness, integration of complex biochemical/biome-
chanical signals, and recapitulation of the soft tissue’s natural
environment. Recently, numerous bioprintable hydrogels have
emerged in the literature, each with decided benefits and
features, with a trend toward multifunctional systems. On one
hand, (modified) natural polymers like alginate,35,103 chito-
san,104 hyaluronic acid (HA),105,106 and gelatin53,107 have
shown good printability, yet limited tailorability. Synthetic
hydrogels like poly(glicidol)108 and PEG109 have excellent
chemical and mechanical tailorability, yet often require
significant optimization to print. The chemical modification of
naturally occurring polymers (e.g., HA, alginate, gelatin) to
produce hydrogels, which a chemist can tailor, has provided a
powerful approach to overcome the limitations of the synthetic
vs natural dichotomy. The recent trend toward creating
multicomponent inks (often from combinations of synthetic/
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natural/modified materials) attempts to circumvent some
limitations of individual compositions. The native ECM relies
on complex networks for function and may be a good design
principle moving forward; however, many of these new
multicomponent ink studies are combinatorial and empirical,
with few systems being rationally designed or generating widely
usable concepts.
Hydrogels generally require a cross-linking step post or during
bioprinting and can rely on light polymerization (akin to a resin)
and ionic cross-linking; however, self-healing and shear-thinning
hydrogels have also emerged which do not need a subsequent
cross-linking step.103,105,110 Cross-linking and the biofunction-
alization of hydrogels via new reactions have been a recent
flourishing area of research with novel strategies like thiol−
ene,35,53,108,111 supramolecular,105,112 light-responsive,113 and
dynamic covalent72,103,111 chemistry all being leveraged to
create new hydrogels with decided benefits in tailorability and
functionality over their parent materials.
3.3. Resins
The class of biomaterial inks that can be cross-linked with light
and used with SLA, DLP, and 2PP techniques are commonly
termed as resins. Light cross-linkable resins are a widely used
class of polymers for the creation of 3D constructs for
biofabrication and span from hard thermoset-like materials to
soft and hydrated hydrogels. Since they are such a widely used
class of materials for biofabrication, they are reviewed separately
in this sectionthe overlap with photopolymerizable hydrogels
(see above) should be apparent and appreciated. Such resins
traditionally form a 3D network upon irradiation with sufficient
UV light, via induced photochemical polymerization. Within
this area, (meth)acrylate resins have been the most widely used
chemistry, including GelMA and PEG methacrylate (PEGMA)
for printing of hydrogels and poly(ester) acrylates for printing of
thermosets. However, any light-initiated polymerization or
cross-linking is amenable. As recent examples, DLP resins allow
large-scale fabrication, and light-induced thiol−ene res-
ins,35,53,108 poly(ester) urethane acrylates,114 and poly-
(propylene fumarate) resins115,116 have emerged as versatile
and promising strategies. UV cross-linkable resins have a wide
range of properties, as their formulations can be optimized with
respect to the type of UV-polymerizable monomers (or
macromers), network density, photoinitiator, and secondary
cross-linking steps taking the ultimate form of a cross-linked
polymer networks ranging from soft hydrated hydrogels to high
performance resins.
A more recent trend within light-polymerizable materials is
the use of visible light for the fabrication. The use of visible-light
photoinitiators like Eosin Y117 and ruthenium redox couples118
allows fabrication to be performed with lower-energy light
sources, minimizing the harmful effects of UV light. While UV
light is traditionally cytotoxic and mutagenic, recent proteome-
wide studies show that cells in the presence of some UV-cross-
linkable materials show no discernible damage to their
proteome.119
Figure 4. Recent trends in materials development, including dynamic and reversibly cross-linked systems like (a), (b) dynamic covalent systems and
(c), (d) supramolecular hydrogels and (e) advanced cross-linking strategies. Adapted with permission from refs 53, 80, 103, 105, and 127. Copyrights
2017 WILEY-VCH Verlag GmbH & Co. KGaA, 2016 Elsevier Inc., 2015 WILEY-VCH Verlag GmbH & Co. KGaA, 2018 Hafeez et al. (published by
MDPI AG), and 2018 WILEY-VCH Verlag GmbH & Co. KGaA.
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3.4. Composites
Composite bioprinting comprises the blending of a polymeric
matrix and particulate reinforcements for added mechanical
strength and/or functionality.64,120 These blends combine the
processability of the polymeric matrix with the mechanical or
chemical identity of the particulate matter. For TERM
application, the most common example is the use of calcium
phosphate or ceramics combined with thermoplastic polymers
for 3D extrusion printing.94,95 The polymeric matrix enables the
processability of the composite, while the calcium phosphate
provides the instructive biochemical cues for enhanced bone
formation.121 While tricalcium phosphate and hydroxyapatite
(HAp) have largely dominated the composite bioprinting,
graphene oxide,96 carbon nanotubes,97 nanocellulose,93,122 iron
oxide nanoparticles,123 alumina platelets,124 and silver nano-
particles125 have all been explored in conjunction with solid
polymers and hydrogels alike.
3.5. Current Trends and Next-Generation Biomaterials
Current and future developments on bioprintable materials
focus on two main areas: (1) chemical complexity and
biomimicry and (2) stimuli-responsive and dynamic materials.
While many studies are beginning to blend the areas above,
complexity and tailorability in materials for biofabrication will
inevitably lead to greater use and adoption of this technique
across laboratories and into the marketplace. A single material
that can address all the challenges associated with fabricating
living tissue appears unlikely, in light of the fact that our own
body uses a palette of materials and their blending for
hierarchical material formation. Future research should focus
on the combinations of systems to recapitulate this instructive,
responsive, and dynamic natural environment.
Traditionally, materials for bioprinting have been poorly
tailorable, with biocompatibility being achieved via nonspecific
protein absorption or nonspecific covalent conjugation,
mechanical properties via concentration or molecular weight,
and little chemical space for material diversity. Across the
different materials classes, at large, there are significant
movements to create biomaterial platforms which can be easily
tailored with respect to the introduction of chemical
functionality. Examples include functionalizable DLP resins115
and hydrogels (Figure 4e)53 and gels for extrusion,35,103 with
click-type reactions coming to the forefront for bioconjugation
strategies.126
Furthermore, chemical complexity is still introduced into the
range of polymers that are 3D printable. Notably, few hydrogels
are widely bioprintable, thus hydrogel ink and bioink
formulations are becoming extremely active areas of research.114
Within hydrogels, novel cross-linking strategies and materials
formulations including supramolecular (Figure 4c and
4d),105,112,120 dynamic covalent (Figure 4a and 4b),103,111
jammed microgels,52 and gel-in-gel51 have emerged as
promising areas of research, often imparting improved
printabilty and dynamic responsiveness of the gels (Figure 4).
DLP printing suffers from a lack of biodegradable and
biocompatible resins for bioprinting; this gap is starting to be
addressed by several research groups115,116 and promises to be
an active area of research in the near future.
A second major effort within biopriting is the movement
toward stimuli-reponsive and dynamic materials for fabrication.
Stimuli-responsive materials are often summated in the moniker
Figure 5. Future direction of bioprinted constructs where the materials can morph and change shape in response to (a) cellular forces or (b) external
stimuli such as magnetic fields and (c) the development of complex stimuli-responsive materials, like logic gate systems. Adapted with permission from
refs 133, 140, and 141. Copyright 2012 Kuribayashi-Shigetomi et al. (published by Public Library of Science), 2018 Springer Nature.
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4D printing,20,128 yet the idea that 3D-fabricated constructs can
change over time has become predominant. Stimuli responsive-
ness with respect to enzymatic activity,110 temperature,129
pH,130 and magnetic fields (Figure 5b)131 has been demon-
strated, while complex mechanisms and feedback loops can be
extrapolated from current generation biomaterial developments
like cell-responsive elements (Figure 5a),132 logic gates (Figure
5c),133 and out-of-equilibrium materials.134 In addition,
dynamic hydrogels as cell culture environments have seen
vigorous investigation over the past few years,135,136 with some
dynamic inks moving into bioprinting.103,105,137 With the
extensive work done within dynamic covalent and supra-
molecular biomaterials,138 this remains a rich area for
bioprinting materials development.
Finally, a current trend toward more complex bioprinting
materials and combinations of techniques and materials is more
recently occurring.139 These complex techniques need not be
complicated, but via the smart combination of simple elements,
one can build up functional units. This trend of hierarchical
structure formation, blending of materials, and gradient
formation mimics some of the features of the biological
microenvironment and is a welcome improvement over single-
material approaches. Admittedly, there is much work to be done
in this area, and the number of combinations and design space
becomes extremely large.
4. CELL SOURCES AND SELECTION
Most of the reported bioprinting studies have used commercially
available cell lines from animal or human sources. This can be
attributed to the fact that cell lines are readily available, with
relatively easy and established protocols for culture and
expansion. Primary cells normally isolated from animal tissues
and organs are another alternative of choice. In this case, the
required steps to isolate the cells from the tissue are normally
complex, and normally a mixed population is obtained, which
might require further steps for the isolation of the cells of
interest. Furthermore, the expansion of these cells in vitro
without losing phenotype can be a limitation. Human primary
cells from donors that have undergone surgery, where a specific
tissue or organ is removed, are also an alternative despite being
less frequent. Furthermore, in this case the resected tissue might
suffer from a pathological condition, which can limit the use for
regeneration strategies. On the other hand, mature and
specialized cells do not seem to be the best choice since they
are often characterized by a limited proliferation capacity and
dedifferentiation when expanded in conventional cell culture
systems.
Most studies were reported where cell lines and primary cells
have been selected and aimed at the validation of the technology
and biomaterials used; only in vitro models or proof-of-concept
studies are normally achieved. In some proof-of-concept studies,
primary cells from the same animal species are used for the
manufacturing of regenerative constructs and tested in vivo in
healthy models or specially developed disease models where the
regeneration potential of the developed construct can be better
validated.
PSCs, either embryonic or induced, can contribute largely to
the advances in the field and can be the ideal biological cell
source for bioprinted approaches for multiple tissue regener-
ation and organ replacement strategies. PSCs have an indefinite
self-renewal ability and plasticity, which allow in vitro generation
of an unlimited number of distinct cell types and have opened
new avenues for regenerative medicine. Embryonic stem cells
(ESCs) allow the generation of all the cells in the body, but
research with these cells is limited in most countries due to
several ethical concerns, which limit their application for
Figure 6.Ontology tree of the embryonic development presenting the three germ layers and an overview of some organ/tissue development for each
layer. Organs or tissues that have been a topic of bioprinting research and covered in this review are underlined. Adapted with permission from ref 168.
Copyright 2013 Edgar et al. (published by Public Library of Science).
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regenerative therapy purposes. An alternative source of PSCs
with less ethical restrictions are iPSCs. Takahashi and Yamanaka
generated the first iPSCs from mice in 2006. This was achieved
using embryonic and adult somatic fibroblasts by introducing
the master regulatory transcription factors Oct3/4, Sox2, c-Myc,
and Klf4, under ESC culture conditions.142 In a follow up work,
the same researchers generated the first human iPSCs (hiPSCs)
using fibroblasts by applying the factors previously described,
currently known as the Yamanaka factors.143
Multiple protocols have been established for the differ-
entiation of iPSCs and ESCs toward specific lineages such as
cardiomyocytes (CMs),144−146 insulin-producing cells,147 kid-
ney progenitor cells,148−152 nerve progenitors,153−155 and many
others. Furthermore, most of these cells have been cultured with
specially developed in vitro protocols to create organoid
structures, with different cell stages during culture being able
to create complex structures with multiple cells types normally
identified in the native tissue or organ. These promising
Figure 7. Skin physiology and its bioprinted counterparts: (a) schematic representation of the skin, (b) histological sections of adult human skin with
different layers and constituents, (c) example of bioprinted skin with layers for dermis, basement membrane, and epidermis, and (d) histological
characterization of the bioprinted and human skin. Adapted with permission from refs 182, 183, and 207. Copyright 2014 Elsevier Ltd., 2015 Sriram et
al. (published by Elsevier GmbH), and 2019 Mary Ann Liebert Inc.
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differentiation protocols are constantly evolving, but further
work is still necessary to ensure that the differentiated cells are of
the intended tissues.156
For the aforementioned reasons, iPSCs seem to be the most
logical choice for the future advances of bioprinted tissues and
ultimately organs. Furthermore, these cells can be expanded in
sufficient amounts to be bioprinted, although the stage of
differentiation that should occur before bioprinting is still
unknown. The main limitations of using such cells and
associated differentiation protocols are the high costs associated
with the cell culture medium and all the growth factors required.
Furthermore, these PSCs require intricate differentiation
protocols, which will require hydrogels that do not affect the
diffusion of growth factors necessary to drive these cells toward
specific lineages. In cases where complex tissues and organs are
the objective, several cells would be needed, and the
combination of multiple cells will certainly require elaborated
protocols with multiple growth factors, which might pose extra
hurdles. For example, in the case of the kidney, more than 20
differentiated cells are harbored in an organ. Even when cell
culture techniques would be developed to maintain and expand
specialized cells in sufficient numbers for bioprinting, such
biological complexity would still pose limits in their use. Mature
cells derived from PSCs could solve these issues if properly
maintained in culture and expanded in a large scale.
Initial PSC bioprinting trials have been recently re-
ported.157−159 Similarly, bioprinting of a specific tissue or
organ with PSC-derived cells has also started to be
reported.34,160−167
5. ECTODERM
Developmental biology has helped to understand the delicate
formation process of several organs, which arise from the three
germ layers (ectoderm, endoderm, and mesoderm). Each of
these layers will give rise to several tissues and organs
individually, but in some cases cross interconnections are also
known to contribute with several tissue and organ complexes
(Figure 6).
The skin and the nervous system are both derived from the
ectoderm, the outermost germ layer of the developing
embryo.169,170 A brief description of the related developmental
process of these tissues provides context for tissue organization
and composition, tissue mechanical properties, and related
repair mechanisms. Overall, this gives tissue-specific insight
relevant for current and prospective bioprinting activities.
5.1. Skin
The skin has the important function of protecting the body from
the surrounding environment, including radiation, dehydration,
temperature extremes, and injury.171 This is achieved through its
well-defined stratified structure and specialized appendages,
such as sebaceous glands and hair follicles. Many of the skin
formation processes observed during development are con-
served in skin repair, allowing a return of function after injury.
However, wound repair can be compromised in cases of extreme
injury (e.g., deep lacerations, burns)172,173 or because of
extenuating factors such as diseases, demographic, or life
style.174 The relative accessibility and seemingly simple layered
composition make skin an attractive proof-of-principle for
bioprinting applications, with examples over the past decade of
in vitro and in vivo skin replacements (Table 2). While this
technology presents many advantages over other biofabrication
techniques, current approaches do not emulate the structural
and compositional heterogeneity of this dynamic tissue and,
therefore, fail to achieve a completely functional mimic.
Improvements will rely on technical and material developments
to harness mechanisms of skin self-assembly and repair.
5.1.1. Skin Structure. Skin has an outer epidermis and an
underlying dermis, separated by a basal membrane, a layer of
collagens, laminins, and glycoproteins (e.g., perlecan, nodigens).
This membrane is a key component of skin and initially
separates the ectoderm layer from the mesoderm, the germ
layers which give rise to the epidermal keratinocytes and dermal
fibroblasts, respectively.175 The basement membrane itself is
produced by the keratinocytes and fibroblasts through the
complementary expression of ECM molecules.175 During
development, ectoderm stratification is initiated by signals
from the underlying mesoderm,169,176 triggering the division of
basal keratinocyte stem cells. These migrate upward, differ-
entiating to form the granular layer and then the cornified layer.
The final outer stratum of dead cornified keratinocytes provides
the body with the final barrier that is continually renewed
through the same stratification process, with complete
epidermal renewal occurring over 48 days.177 The basement
membrane is essential to this renewal process by forming a niche
for epidermal stem cells, regulating the epithelial stratification
process by controlling growth factor diffusion and providing cell
adhesion cues.178 As the epidermis is primarily held together by
cell−cell junctions,179,180 it is assumed that the dermis provides
most of the structural integrity of the skin.181
The major cellular constituent of the dermis is the dermal
fibroblast, with an interplay of signaling between the dermis and
epidermis driving epidermal stratification, the formation of
appendages (e.g., hair follicles, sweat glands), and the regulation
of dermal homeostasis (Figure 7a,b).178,182,183 The upper
dermal layer adjacent to the basal membrane, known as the
papillary dermis, is comprised of densely packed 10 μm collagen
fibrils within an interpenetrating network of elastin that is
populated by papillary dermal fibroblasts. Below this is the
reticular dermis, exhibiting an ECM of loosely organized, larger
50 μm collagen fibrils with the limited presence of elastin and
with the presence of distinct reticular dermal fibroblasts.181−183
A determining factor of collagen fibril size within the skin is the
presence of decorin, a proteoglycan which is known to produce
smaller collagen fibrils in vivo184 and in vitro185 and is more
highly expressed within the papillary dermis by resident papillary
fibroblasts.186
As a result of structural and compositional differences, these
layers exhibit distinct mechanical properties, with the highly
fibrillar papillary dermis having a stiffness an order of magnitude
higher compared to the loosely packed reticular dermis.181
Differences in mechanical properties are also suggested to
depend on proteoglycan distribution within these layers,
imparting a viscoelastic behavior based on the supramolecular
assembly of these molecules. The mechanical properties of skin
also differ at different locations of the body187 and have in-plane
anisotropy at different locations,188 which correlates to changes
in collagen and elastin content and overall ECM orientation.189
This variety in tissue and different methods of evaluation
produce measurements ranging from 0.02 to 58 MPa.190 In
addition to skin integrity, tissue stiffness also has implications for
the cells residing within these layers, which are reported to
respond to mechanical cues.191−193 This reported heterogeneity
of skin, in terms of tissue stratum and tissue location, and the
impact this can have on mechanical and mechanobiological
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aspects provide criteria as well as inspiration for the develop-
ment of tissue-engineered constructs to facilitate skin repair.
After injury, a rigid fibrin-based ECM structure (a blood clot)
forms, and fibroblasts migrate to the location, producing
collagen to create a wound bed.172 The mechanical properties
of the wound bed also play a role in the healing process, where
tension stimulates fibroblasts to proliferate194 and differentiate
into myofibroblasts,195 a contractile phenotype that facilitates
wound closure.196 During this time, the wound bed increases in
stiffness197 in a matter of days, from approximately 18 kPa to
greater than 40 kPa. This has a subsequent impact on epithelial
cells, which are known to proliferate more on stiff substrates and
require a substrate stiffness greater than 40 kPa to effectively
close a breach in the epithelial barrier.198−200 However,
excessive tension applied during a critical time window in the
healing process can trigger abnormal fibrotic ECM deposition
and leads to excessive (hypertrophic) scar formation.195,201
With a market value of approximately $6.7 billion,172 interest
in skin wound healing continues to grow. These efforts have
been driven by academic research into skin dynamics, the search
for improved clinical wound healing applications, and the search
by the cosmetic industry for an ethical alternative to animal
testing of cosmetics.202
5.1.2. Skin Bioprinting.One of the earliest examples of skin
bioprinting applied DOD printing to manufacture layered
skin.203 Layers of collagen were dispensed initially followed by
intercalated layers of fibroblasts and collagen followed by layers
of keratinocytes. Constructs were cultured using an air−liquid
interface, and substantial shrinkage was observed.
Laser-assisted bioprinting has also been used, where laser
irradiation transfers encapsulated cells to a target slide with high
precision and resolution to generate printed skin with a
biomimetic layered arrangement.36,204 Initial studies by Koch
et al.204 showed the capability of using laser-assisted bioprinting
to manufacture layered constructs of fibroblasts and immortal-
ized keratinocytes. Michael et al. bioprinted on top of an
acellular dermal matrix, depositing 20 collagen layers that
incorporate fibroblasts and another 20 layers containing
keratinocytes.36 The constructs were implanted in nude mice
with a dorsal skin chamber, and histological results showed an
integration of the constructs with the surrounding tissue.
Neovascularization was also observed.
Full thickness skin with dermis and epidermis layers was
recently achieved by Pourchet et al. via a piston-driven extrusion
approach.205 After an initial validation with mouse fibroblasts,
primary human dermal fibroblasts were used to create the
dermis layer, and a layer of human epidermal keratinocytes was
seeded on top to mimic the skin structure. A comparison with
healthy skin showed similarities; however, after 26 days in
culture, differences were noted including cellular organization
and the thicknesses of both epidermis and dermis. A similar
approach was followed by Cubo et al.,206 again with fibroblasts
deposited within fibrin as the dermal layer and keratinocytes
dispensed on the construct surface. The bioprinted skin was
implanted in immunodeficient mice and sutured in place. After 8
weeks, explants stained positively for human skin markers, and
histological characterization showed similar stratified architec-
ture when compared with human skin.
Increasingly complex methods include creating multimaterial
stratified structures, as recently described by Derr et al.207 This
multilayered approach of sequentially bioprinted cell/hydrogel
compositions resulted in a stable skin-like construct (Figure 7c).
While the composition of the layered structure does not directly
reflect native skin, the resulting skin mimic was mechanically
stable, produced analogous cellular and ECM distribution, and
achieved appreciable barrier function (Figure 7d).
Bioprinting directly onto the wound has also been tested in
small- and large-size animal models.208−210 The easy access of
skin-related wounds has facilitated these early examples of direct
in situ bioprinting, providing a proof-of-principle of future
possibilities such as the application of bioprinting in a clinical
setting.
5.1.3. Skin Biofabrication Considerations. The bioprint-
ing examples discussed so far provide a robust proof-of-concept
application, due in part to the intrinsic ability of bioprinting to
recreate the layered architecture of skin. The manual creation of
hydrogel layers was the original approach and is technically
simpler, but this lacks control in terms of composition and
cellular resolution and has also been shown to be less
mechanically stable.211,212 Electrospinning has also been used
to create a layer of nonwoven nanofibers as a mimic of the
basement membrane layer; however, the resulting layers are
large compared to the native dermal/epidermal transition and
may impede the intimate crosstalk between the two layers.213,214
In contrast, examples of skin bioprinting have shown that it is
possible to have accurate planar (XY) deposition of different cell
types within a skin construct, such as the controlled inclusion of
melanocytes to provide the skin with pigment.212 Further
control over the heterogeneity throughout the depth of the
construct is also possible, resulting in a skin mimic that closely
reflects the native tissue organization in terms of cell
populations, composition, and structure.212
As the technology continues to develop, attempts should
continue to focus on improving the level of mimicry. The
majority of current approaches employ collagen type I, with a
few exceptions including fibrin. While both are present in the
native ECM and wound bed, respectively, additional compo-
nents are often ignored. Further, there have been limited
attempts to recreate the different fibrillar regions within the
dermis. Looking at the process of skin development described
above, these two aspects are not mutually exclusive. The
concentration of decorin, a proteoglycan, changes throughout
these layers, and its presence influences the assembly dynamics
and, therefore, the size range of collagen fibrils. Thus,
incorporating this molecule might address both the composi-
tional and structural heterogeneity of the tissue.
Mechanics of bioprinted skin is also often overlooked, with a
few reports dedicated to measuring the mechanics of these
replacement tissues.215,216 The mechanical properties of skin are
important for two reasons: the replacement skin must ultimately
provide a physical barrier with suitable strength, and the
biomechanics of the tissue directly affect the quality of wound
healing. As discussed above, both fibroblasts and keratinocytes
are influenced by the elasticity of their surrounding environ-
ment, and it is this aspect where bioprinting and the
development of new and novel bioinks can excel. The ability
to create different layers with mechanics specifically tuned to the
resident cell type provides a powerful mechanism to influence
wound healing. This could be even further harnessed by creating
materials that respond appropriately over time and promote the
different stages of wound healing, such as migration,
proliferation, and differentiation.
In terms of “raw materials” for bioprinting, a wide number of
cell sources have been employed for the manufacturing of skin
constructs. Initial approaches described above mainly used
immortalized cell lines from humans, animals, or a combination
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therein to generate proof-of-concept approaches.36,203,204
Primary cells have also been used, and a number of stem cell
sources have been identified, some with clinical rele-
vance.208,217−219
Figure 8. (a) Cortex is the outermost region of the brain and is part of the CNS that is most susceptible to bioprinting because of its stratified structure
comprising different neuron types. This has been emulated by printing neurons within a multilayered hydrogel, with initial indications showing the
initial formation of interlayer connections. (b) The spinal column is a more challenging structure within the CNS to recreate. Shown is a combination
of hydrogel bioplotting, used to create structural support, and bioink containing various neural progenitors. Deposited in a manner to reflect the
anisotropic arrangement of the spine, deposited cells showed good viability and directional growth along the axis of the printed spinal cord. Adapted
with permission from refs 166 and 252. Copyright 2015 Elsevier Ltd. and 2018 WILEY-VCH Verlag GmbH & Co. KGaA.
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5.1.4. Skin Future Outlook. The most attractive clinical
application for skin bioprinting is to treat partial and full
thickness burn wounds, based on a clear medical need to quickly
replace large swathes of skin and the current lack of wholly
effective treatment options. However, a number of obstacles
exist before such technology will be present in the operating
theater, including regulatory restrictions. Bioprinting is still an
emerging technology, and as such, the regulations for safety
compliance in clinical applications are still being written.220
Furthermore, current approaches, such as skin grafts and spray-
on cell encapsulations, are already established and are
comparatively less technically demanding and, therefore, less
expensive.217,221,222 Promoting the adoption of a bioprinting
technique requires that a clear advantage is presented, including
medical performance and financial benefit.
Despite the promising in vivo results obtained in some studies,
current bioprinted skin substitutes remain an oversimplification
of the complexity of native skin. The skin also includes
appendages, such as hair follicles and sweat glands, and is highly
innervated, both of which improve skin function and the quality
of skin repair.223,224 Furthermore, while healthy skin is a highly
vascularized tissue, providing resident cells with sufficient
nutrients, recent reports suggest that excessive formation of
new blood vessels within the wound bed can impede healing and
contribute to scar formation.225 With the overall aim of
incorporating different cell types in specifically designed spatial
configurations throughout a 3D construct, bioprinting alone is
capable of reconstituting in a meaningful and functional way
these different tissue components. Although not currently taken
into account, the impact of incorporating these elements on the
success of wound healing will present bioprinting with a unique
advantage over other techniques.
5.2. Nervous System
The nervous system is divided into the central nervous system
(CNS) and the peripheral nervous system (PNS), two neural
networks that work in concert to regulate homeostasis and sense
and respond to external stimuli. The CNS refers to the brain and
the spinal cord, while the PNS comprises the neurons
distributed throughout the body. The key functional unit of
both systems is the neuron, a specialized cell with long
extensions (axons and dendrites) that connect to other neurons
or tissues to transmit neuroelectric signals throughout the body.
In addition, both systems contain specialized glial cells that
provide critical support for neural function and impact nerve
tissue repair.
During development, neural progenitors of both the CNS and
PNS undergo a spatiotemporally orchestrated migration
throughout the fetus and differentiate upon reaching respective
destinations. At this time, axons and dendrites extend from the
neural cell bodies and follow haptotactic and chemotactic cues
to create connections with other neurons or with tissues and
organs.
The PNS has an intrinsic regenerative capacity that relies on
conserved pathfinding mechanisms in combination with a
conducive ECM and trophic support from glial cells.227,228 In
contrast, glial and non-neuronal cells of the injured CNS form
scar tissue that impedes regeneration.229 Owing to the restricted
access and delicate nature of CNS tissue in vivo, bioprinting has
focused on developing in vitro CNS models. By comparison, the
PNS is more accessible for an intervention when tissue damage
is too extensive; recent bioprinting examples aim to emulate the
supportive ECM and glial cell organization of the PNS to
improve regeneration in these extreme cases (Figure 9a).230 To
advance the application of bioprinting to recreate or repair the
CNS and PNS, the tissue composition and structure must be
appreciated along with an understanding of conserved and
distinct mechanisms of these tissues during development or after
injury.
5.2.1. Central Nervous System (CNS). The CNS is often
described as tightly packed neural and glial cells, with the
majority of self-organization driven by spatiotemporal gradients
and cell−cell interaction.231−233 There are approximately 86
billion neurons in the brain and an almost equal number of glial/
non-neural cells.234 A neuron forms a synapse with another
neuron to create a connection, and one neuron is capable of
contacting up to 1000 other neurons, resulting in over 60 trillion
synapses within the brain.232 These connections bridge activity
across different regions, from the outer cerebrum, where
learning and other higher functions occur, to the cerebellum,
responsible for muscle coordination, to the brain stem, which
controls primary functions (e.g., heart rate, breathing). Finally,
the spine serves to transmit signals to and from the body.235 The
majority of CNS bioprinting activities has focused on recreating
the outermost cortical layer of the cerebellum and its well-
defined multilayered structure, which underpins the majority of
complex higher functions (Figure 8a).
In addition to neurons, there are also CNS glial cells that
regulate and maintain neural function, including oligodendro-
cytes and astrocytes. In particular, oligodendrocytes myelinate
axons (wrap them in an insulated fatty layer) to help signal
conduction; many neurodegenerative diseases, such as multiple
sclerosis (MS), are the result of pathological demyelination of
neurons.236 Throughout the CNS, there is an expansive blood
vessel network to supply nutrients with astrocytes regulating
nutrient flow and moderating the blood−brain barrier (BBB) to
ensure that noxious molecules do not enter the brain via the
bloodstream.
The ECM of the CNS is the perineuronal net (PNN),237
which distinctively lacks an ECM ultrastructure compared to
other organs and has limited amounts of collagen type I and
fibronectin. Instead, the PNN is comprised of the membrane-
forming collagen IV and hyaluronan that wrap around the
individual dendrites and neural cell bodies. The PNN
incorporates glycoproteins tenascin-R, tenascin-C, a number
of proteoglycans, and proteins such as Semaporin 3A.238
Because many of these molecules inhibit axon growth, this
inhibitory PNN sheath is suggested to direct synaptic formations
and maintenance during learning.231,239 This milieu of cells,
myelin, and ECM creates a relatively soft tissue, with elastic
modulus measures ranging from 0.689 to 2.51 kPa depending on
where and how the measurement is performed.240 The
mechanical properties of this tissue are also suggested to play
a critical role in creating the distinctive ridges (gyri) and valleys
(sulci) of the developing brain.233
Astrocytes form a scar around the site of a CNS injury,
creating amechanically soft boundary that protects healthy brain
tissue from immune cells coming from the disrupted BBB.227,236
The center of the lesion contains fibrinogen and collagen type I,
which trigger astrocytes to adopt a reactive phenotype,
producing collagen type IV and proteoglycans.229,233,241−243
While collagen type IV promotes neurite growth, it also
sequesters the other biomolecules to inhibit nerve growth
through the barrier. Attempts to prevent scar formation delay
BBB repair and result in more damage to healthy CNS
tissue.244,245 However, a degree of neural repair across the
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injury is achieved when the astrocyte interaction with collagen
type I is blocked.241
5.2.1.1. CNS Bioprinting. The delicate nature of the CNS has
focused therapeutic developments on injectable hydrogel
systems for in vivo applications.246−248 However, CNS
bioprinting has attracted interest for in vitro models that
emulate the distinct layered structure of the cerebral cortex,
owing to the intrinsic layering ability of the technology. While
earlier work established general feasibility, a number of examples
have emerged which showcase the promise of this approach.
An initial example of feasibility was generated by Tao et al. in
2006,249 using a modifiedHP inkjet printer to deposit sequential
layers of fibrin, thrombin (for cross-linking), and rat primary
cortical neurons in suspension. Generating a layer thickness of
around 60 μm, this fibrin construct achieved an estimated elastic
modulus of 2.9 MPa. However, the low viscosity of the cell
suspension led to a relatively diffuse distribution of cells,
precluding any fine determination of neural cell placement; the
stated theoretical 85 μm resolution droplet placement was not
observed in the final pattern. However, electrophysiological
assessment revealed that these cells not only survived the
process but also generated a functional neural network.
Work from the Yoo lab250,251 also performed a sequential
deposition process, this time collagen type I at a pH of 4.5 (pre-
cross-linking) and a nebulized spray of calcium carbonate (to
increase pH and initiate cross-linking), followed by deposition of
embryonic astrocytes and cortical neurons in suspension. While
no assessment of cell function, printing resolution, or
mechanical properties was reported, this proof of principle
verified that the brief exposure to acidic conditions was not
detrimental to cell viability and made it possible to maintain
distinct hydrogel regions or layers of different cell types in
specific patterns.
Recent work has focused on the deposition of neural cells
within a hydrogel carrier. Lozano et al. created a multilayer
hydrogel with distinct cell populations via the in-line mixing of a
gellan gum hydrogel and ionic cross-linking solutions during the
bioprinting process (Figure 8a).252 While this relatively manual
process resulted in low-resolution patterns, it provides a nice
example of recreating the lamellae of the cerebral cortex and
initial indications of forming a neural network between distinct
layers.
With the aim of improving pattern fidelity and resolution,
others have focused on developing approaches where the
hydrogel maintains both printability and sufficient cross-linking
upon deposition. This has been achieved with either thermally
induced cross-linking, where bioprinting and deposition
collection occur at different temperatures,247 or sequential
thermal cross-linking during the initial deposition followed by a
secondary cross-linking solution to further stabilize the resulting
structure.253 These approaches created cell-laden gel filaments
with a resolution ranging from 200 to 250 μm which could be
stacked during printing to form an open, porous 3D structure.
As with other bioprinting endeavors, the challenge of
achieving a construct with a material composition and
mechanical properties that are appropriate for the biological
application while being constrained by processability is a
mainstay. This is represented well by Joung et al., as shown in
Figure 8b, who performed an extensive study on various material
combinations to create a CNS spinal graft.166 While initial
attempts to bioprint fibroblasts were successful using GelMA or
gelatin/fibrin gels, spinal neural progenitors (sNPCs) derived
from human iPCSs did not survive this process. Instead,
Matrigel as an alternative bioink resulted in successful
bioprinting of both sNPCs and oligodendrocyte precursor
cells (OPCs). Meanwhile, the structural component of the
scaffold was realized by bioprinting an alginate and methyl-
cellulose (MC) blend to form an oriented array of micro-
channels; different AG/MC compositions and different ionic
cross-linking solutions (calcium chloride, barium chloride) were
trialed. During bioprinting, the channels were filled with a cell-
laden Matrigel to create a composite hydrogel structure. The
final AG/MC composition used was capable of creating 150 μm
channels and had an elastic modulus of 55 kPa; while this is
stiffer than the native spinal tissue, it was found that softer
compositions were not mechanically stable enough to realize the
final structure.
5.2.1.2. CNS Fabrication Considerations. Overall, Joung et
al.166 report a stiffness ranging from 40 to 200 kPa, while Dai et
al.253 report a range of properties from 0.8 kPa to almost 5 kPa,
the latter being within the range of elasticity often reported in
the brain. However, themechanical properties of the healthy and
injured brain can be different, and reports suggest that stiffer
substrates are detrimental for CNS regeneration.227,254,255
Ultimately, a timely shift in stiffness could achieve ultimate
repair by promoting cell proliferation at one stage, followed by
differentiation and, ultimately, maturation.256,257 The develop-
ment of a bioprintable material that undergoes appropriate
temporal changes in mechanical properties while maintaining
cell viability remains a challenge.
The biological epitopes within the hydrogel are also of critical
importance. Until now, material selection has largely focused on
printability and cell viability, with the majority of studies using
collagen type I and fibrin as mainstays of the bioprinting domain.
However, these two materials are only present during a state of
injury and are known to promote a reactive astrocyte phenotype
that produces inhibitory molecules. Therefore, the use of these
materials is seemingly counterproductive when attempting to
create an environment that promotes neural network formation
or induce a repair. Other materials, such as Matrigel or other
laminin-rich substitutes, are better at emulating the native
environment though present challenges in terms of printability.
Other possible materials include more bioinert options, such as
alginate or gellan gum; however, these typically need to be
modified through the addition of cell-adhesion peptides for
appropriate cell response.258 Hydrogel materials capable of
sequestering endogenous CNS ECM components, thereby
mimicking the formation of a functionally appropriate PNN
microenvironment that promotes neural and glial cell self-
organization, are currently unavailable.
Toward achieving a complex biomimetic construct, the
inclusion of all appropriate cell types within the CNS is required
to achieve appropriate ECM production and functional self-
organization. The studies outlined above provide a number of
examples of the many CNS cells sources currently available (as
reviewed byGage and Temple). Possibilities range from primary
cells (typically embryonic to ensure viability), to adult NSCs, to
reprogrammed iPSCs. Both NSCs and iPSCs require a more
thorough validation of the phenotype attained, but hold the
most promise in terms of a clinical application that is patient-
specific and nonimmunogenic. When determining neural
phenotype, morphological and marker expression alone are
not sufficient to indicate a functional tissue. Instead,
functionality in terms of conductive of neural signals is needed,
as showcased by both Gu et al.259 and Joung et al.166 While
attaining appropriate and functional cells is a considerable
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challenge, the field of neuroscience has a number of toolsets
available to this end.
5.2.1.3. CNS Future Outlook. For the moment, the
application of CNS bioprinting is limited to in vitro model
development, although the goal of repairing neural networks for
in vivo applications represents a conspicuous challenge. The
advent of the brain organoid, where stem cells are coaxed to
form a “mini-brain” through self-organizing, has drawn attention
to in vitromodels for studying brain development.260 While this
might seemingly obviate the need for bioprinting, brain
organoids still have a number of limitations such as throughput,
control of cell diversity, and direction of appropriate cell
patterning. In this sense, bioprinting can facilitate investigations
by enabling the prepatterning of organoid composition to help
direct and drive the self-assembly process.
As increasingly more representative 3D models develop,
extending beyond the layered cerebral cortex to include the
brain stem or cerebellum, improved monitoring will also be
required to better understand the structure/function of the
created tissues. In parallel progress, complementary fields of
research will accelerate this development, making it possible to
monitor activity in a printed brain via 3D electrodes261,262 or
through light sheet calcium imaging.263,264
5.2.2. Peripheral Nervous System (PNS). After the
migration of neural crest cells and their subsequent differ-
entiation into specific peripheral nerve lineages, neural cells are
organized into clusters called ganglia located throughout the
body.265−268 These cell clusters extend axons to innervate
specific tissues, classified as afferent (transmitting from the
body) or efferent (transmitting to the body). As axons extend,
glial progenitor cells migrate along the axons, proliferating and
differentiating into mature Schwann cells (SCs) that support
axonal function. Once an axon reaches its target tissue, some SC
progenitors can also migrate past axons into the target tissue and
differentiate into various specialized cells that act as innervation
points within tissues, such as terminal SCs or even other neural
ganglia.266,269,270
The PNS is functionally grouped as sensory, sympathetic, and
parasympathetic. Efferent sympathetic ganglia are located along
the exterior of the spinal column and extend into the body,
passing on signals that regulate homeostasis while providing the
“flight or fight” physiological response to a perceived threat (e.g.,
adrenaline release, increased heart rate). Efferent parasympa-
thetic ganglia are uniquely located within various organs and
extend throughout each respective tissue, transmitting signals
coming directly from the CNS.271
Sensory ganglia (afferents) are located close to the spine and
have axons which connect the spinal cord to tissue throughout
the body, providing a path for sensory inputs, such as pain and
temperature, as well as homeostatic feedback.268 Though
technically not considered a part of the PNS, somatic motor
axons also extend from the spinal cord and bundle together with
sensory axons to innervate muscle tissue. These bundle tracts of
axons form nerve fibers with which we are familiar, such as the
sciatic nerve or ulnar nerve (origin of the “funny bone”
sensation). SCs are present throughout PNS nerve fibers, either
myelinating axons or generally supporting neural function.270
A peripheral nerve fiber has a hierarchical organization,
starting with the endoneurium that envelopes axons and SCs to
form endoneurial tubes around each axon with tube diameters
corresponding to the resident axons (2−20 μm).272−274
Endoneurial tube boundaries are demarcated by ECM proteins
synthesized by resident SCs, including type I and type III
collagen fibrils,275,276 and a basal lamina of collagen type IV and
laminin molecules.277 The ECM of the endoneurium between
endoneurial tubes is comprised of hydroscopic GAGs and also
includes fibroblasts.278,279 This highly heterogeneous structure
has an estimated elastic modulus of 55 kPa, and overall, axons
occupy approximately 50% of the cross-sectional area.280−283 A
perineural epithelial cell layer, or perineurium, envelopes the
endoneurium to form fascicles and serves as a blood−nerve
barrier, similar to the CNS; groups of fascicles form the nerve
fiber properly, enveloped by the epineurium and mesoneurium
membranes.284,285 The epineurium is comprised predominantly
of collagen type I with an estimated elastic modulus of 22 kPa,
whereas the perinerium has a modulus of 89 kPa and contains
collagen type III.275,280,286
A severed peripheral nerve is separated into the viable fiber
segment still connected to neuronal cell bodies (the proximal
nerve segment) and the dead/dying segment that used to
innervate target tissues (the distal nerve segment).287 The distal
segment experiences Wallerian degeneration that removes
debris from any intact endoneurial tubes.288,289 Distal SCs
dedifferentiate into a regenerative phenotype, proliferate, line
the endoneurial tubes to assume the distinctive bands of
Büngner formation, and produce proteins to promote axon
growth.290−292 Meanwhile, axons sprout from the proximal
stump and form growth cones, a specialized structure that
responds to a combination of contact-mediated (haptotactic)
and diffusible (chemotactic) cues to guide a regenerating axon
to a target tissue.288,293,294 The endoneurial tubes present
laminins, oriented collagen fibrils, and a 3D microchannel
architecture that directs neurite growth toward target tissue.292
In some cases, a tube (or “nerve guide”) can help to bridge the
defect (entubulation), acting to concentrate the fibrin coming
from the injured stumps. This forms a fibrin cable that acts as a
scaffold for SC migration and axon growth, in contrast with the
CNS where fibrin triggers a reactive glia phenotype that inhibits
repair. The fibrin cable fails to form when the nerve defect is too
long, and the current golden standard bridges the proximal and
distal stumps with an autogenic or allogenic nerve graft. This
approach is successful because of the native endoneurial
microarchitecture and, for autografts, the native SCs which
support efficient axon regeneration. However, the limitations of
nerve grafts have driven the development of alternatives; the
reader is directed to extensive reviews on other biofabrication
approaches by Daly et al.,295 Kehoe et al.,296 and Wieringa et
al.297
While the bioprinting of neural cell bodies in this context
serves little purpose, the bioprinting of SC-laden constructs is a
promising approach (Figure 9a). SCs provide neurotrophic
growth factors and create essential ECM components, and
incorporating them within a permissive anisotropic architecture
is considered beneficial for long gap repair.
5.2.2.1. PNS Bioprinting. Recent bioprinting efforts have
focused on achieving better PNS repair by creating nerve guides
that incorporate SCs and other cell types known to improve
nerve growth (Table 3). The most original is the formation of a
nerve guide tube comprised entirely of cells, assembled via the
Kensai bioprinting method of placing cell spheroids onto a
needle array to form 3D shapes (in this case, a tube) (Figure 9d).
Early attempts utilized fibroblasts (Figure 9c),298 while later
efforts applied a novel gingival mesenchymal stromal cell
(MSC).299 This approach relies on intrinsic fusion between
cellular spheroids to maintain the tube structure, and both
studies state that the tube mechanical properties need to be
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further explored. Regardless, both showed successful nerve
repair, and the use of gingival MSCs in the latter example
presents an interesting cell source since facial MSCs derive from
a neural crest origin. As such, these cells represent a unique
source of progenitors that generate SCs.300
A nerve guide design developed by Owens et al. was also
comprised of only cells, but this time forming multiple oriented
channels approximately 500 μm in diameter.301 The approach
relies on the assembly of oriented agarose filaments to define a
support structure into which fused filaments of cell aggregates
are placed to form a tube. While this has been performed in an
automated fashion in previous reports,302 the current work
performs these steps manually. The multichannel structure was
created by placing 500 μm diameter agarose filaments during
device assembly, which in principle can be removed after cell
fusion. Altering the cellular composition of the consecutive
filament cellularly generated compositional heterogeneity by
having MSCs in the filaments placed around the epineurial
periphery and more SCs located within the central endoneurial
compartment. The structure was supported by a traditional
nerve guide during implantation and showed clear nerve
regenerative capacity in a rat animal model. However, poor
mechanical integrity of the construct required that the agarose
filaments which defined the microchannels were left in place,
effectively blocking axon growth in a major region of the guide
cross section.
A series of reports from the Chen lab employ HA hydrogels as
an SC carrier and the extrusion of the cell-laden gel to form an
oriented array of filaments.77,78 A key aspect of this strategy is
the deposition of the filament structure into a polyvinyl alcohol
(PVA) bath, which acts to counter the filament buoyancy and to
stabilize the filament diameter at approximately 200 um; the
bath also facilitates rapid cross-linking via thrombin or calcium
for HA gels blended with fibrin or alginate, respectively. This
results in exquisite formation of a self-supporting structure of
fused filaments shown in Figure 9a, with consecutive layers
oriented at 80, 90, or 100°. This strategy forms 100 μmdiameter
microchannels between the filaments, all with a general
orientation to better direct nerve growth. While these are
again larger than endoneurial tubes and no in vivo testing has so
far been reported, in vitro evaluation of SC growth shows good
viability, and filaments are shown to exhibit oriented fibrin fibrils
that induce cell alignment reminiscent of the bands of Büngner.
5.2.2.2. PNS Fabrication Considerations. The majority of
bioprinting efforts center on creating a supportive environment
for nerve regeneration (Table 3). While none of the studies
discussed here evaluate the mechanical properties of their
bioprinted constructs, the elasticity of the environment is known
to have an impact on axon extension. Many reports have shown
that peripheral axons have optimal growth on substrates with an
elasticity greater than 1 kPa, in contrast with 55 kPa of the
endoneurium.303,304 However, while the intact basal lamina and
myelin component around a single axon also have an elasticity of
55 kPa,305 the cytoskeleton of SCs grown on such substrates
achieves an elasticity of approximately 1.3 kPa.306 These findings
in combination with observations that axons adhere to SCs
during regeneration suggest that the complex combination of
extracellular and cellular mechanics is required to create the
optimal microenvironments for nerve repair.
Further practical restrictions must be considered for surgical
implantation of a nerve guide. In this regard, the suitability of
both cell-only and hydrogel-based nerve guides remains an open
question. Given the target tissue elasticity of approximately 50T
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kPa and the concurrent practical need to surgically immobilize a
nerve guide in place, the most viable solution is to combine
bioprinted structures with a traditional nerve guide or generate a
multimaterial structure with a more resilient epineurium-
mimicking outer layer.
The use of fibrin gel matches the composition of the natural
PNS repair environment and provides a suitable substrate to
stimulate repair, in contrast with the CNS. Further inclusion of
additional factors, such as collagen type I, collagen type IV, and
laminin, may also prove beneficial. However, many of these
structural proteins can be produced and self-assembled by cells
incorporated within the construct.300,307
A number of cell types have been shown to promote nerve
repair, including adipose- or bone-derived MSCs. However, SCs
remain the most likely candidate as they produce both ECM and
growth factors suitable for nerve repair.307−310 For research
purposes, SCs are available as immortalized cell lines or isolated
primary cells, though care must be taken regarding passage
number and phenotype.311−313 For more clinically relevant
applications, it is possible to derive SCs from bone-derived
MSCs, a readily available, patient-specific cell source.314 The
possibility of generating SCs from gingival MSCs, a neural crest
derivative, also presents an interesting approach.300
With respect to nerve guide development, recreating an
appropriate microarchitecture remains a challenge.297 The
oriented filament design presented by England et al.77 provides
an array of microchannels to direct nerve growth across a gap
and emulates the aligned collagen fibrils of the native PNS ECM
(Figure 9b). Presenting a regenerating nerve with a bulk
hydrogel is known to impede nerve repair over long gaps;
therefore, the incorporation of endoneurial-like anistropic
porosity remains a critical objective.315,316 Bioprinting fugitive
structures within constructs could be a possible strategy to
realize directed porosity after fabrication;317,318 however,
continued technical development is required to attain
bioprinted structures of the same resolution as the endoneurial
microstructure. Until then, a combination of bioprinting and
FDM techniques represents a more accessible option to
combine hydrogels with fugitive structures of an appropriate
scale.319,320
5.2.2.3. PNS Future Outlook. Nerve guides are commercially
available for clinical use, and research continues in this field,
highlighting the immediate need for improved PNS nerve repair
solutions.296 Once bioprinting technology overcomes fabrica-
tion limitations, regulatory hurdles, and productions costs, the
development of a bioprinted clinical solution for PNS repair is a
realistic goal.
However, the bioprinting of neurons and neural integration
within the context of complex tissue formation remains to be
addressed. For example, parasympathetic ganglia exist within
tissues, and this organization can be recreated via bioprinting.
While a source for parasympathetic neurons still needs to be
established, incorporating these cells would create more
biologically representative tissues.269,321,322 Concomitantly,
the bioprinting of SCs or specific ECM components within an
engineered tissue could be an interesting strategy to promote
extrinsic innervation from the sympathetic and sensory
populations. As the bioprinting and regenerative medicine fields
at large move to create more functional tissues, the inclusion of
the neural component, until now largely ignored, needs to be
addressed, and the further development of bioprinting
technologies and associated bioink materials will be essential
to this process.
6. MESODERM
The mesoderm is the middle layer of the three germ layers
developed from the inner cell mass during gastrulation.
Gastrulation results in the formation of the primitive streak,
which is divided along the anterior−posterior axis based on
differential gene expression in cells. The anterior primitive streak
gives rise to the definitive endoderm (discussed below), and its
lineage-specific organs follow the formation of the gut tube along
Figure 9. (a) Envisioned application of bioprinting to repair a peripheral nerve defect by directly depositing ECM and cells to recreate the
characteristic anisotropic architecture. (b) A bioprinted anisotropic hydrogel structure containing SCs to provide trophic support for regenerating
neurites and oriented open-pore structures to permit neurite growth across the nerve defect. (c) Cell aggregates carefully for Kensai method
bioprinting and (d) aggregates arranged to form a scaffold-free nerve conduit, used to bridge a nerve defect to elicit repair. Adapted with permission
from refs 77, 230, 298, and 299. Copyright 2018 Elsevier Ltd., 2016 Elsevier B.V., 2017 Yurie et al. (published by Public Library of Science), and 2018
Zhang et al. (published by Springer Nature).
Chemical Reviews pubs.acs.org/CR Review
https://dx.doi.org/10.1021/acs.chemrev.9b00789
Chem. Rev. XXXX, XXX, XXX−XXX
T
the growth factor gradient established along the dorso−ventral
axis. Simultaneously, the posterior streak gives rise to a definitive
mesoderm and the resulting tissues including musculoskeletal
(cartilage and bone), cardiovascular and immune systems,
kidneys, and gonads.
6.1. Cartilage
Cartilage is the elastic connective tissue formed in the early
stages of embryonic development that serves as a template for
bone growth and persists in some parts of the mature skeleton. It
is present in the body in three main forms: elastic cartilage,
fibrocartilage, and hyaline or articular cartilage, each accounting
for specific functions.323,324While all the three cartilage types are
characterized by a high water content (65−80 wt %) and a
collagen II- and GAG-rich ECM supported and maintained by
chondrocytes, there are substantial differences between them.
Elastic cartilage, located at the outer ear and epiglottis for
example, has an elastin-rich ECM that provides elasticity to the
tissue, whose main function is to provide support while
maintaining structure and shape upon repetitive bending.323,325
Fibrocartilage, the toughest of the three, has a collagen I-rich
ECM (as well as collagen II) that brings extra stiffness and
reduced elasticity to the tissue. Fibrocartilage is thus located at
high load-bearing areas such as the meniscus, the annulus
fibrosus of the intervertebral discs, and the entheses.323,325
Hyaline or articular cartilage is present at the end of long
bones, such as the knee, elbow, hip, and shoulder joints, serving
as an interface that reduces the friction and allows rotational and
translational movements while bearing and transferring the
loads applied to the synovial joints during articulation.326
Articular cartilage, isotropic in structure at birth, progressively
develops into an anisotropic structure as a consequence of the
continuous loading to which it is subjected and appears well-
defined at skeletal maturity.327,328 Adult hyaline cartilage is
characterized by three distinct zones (superficial or persistent,
intermediate or proliferating, and deep or hypertrophic zones),
each with different ECM components, and the arcade-like
collagen II organization along the depth of the tissue.324,328−330
The superficial zone (10−20% of the cartilage thickness) is
responsible for minimizing friction and, thus, is covered by a thin
layer (few hundreds of nanometers up to a micrometer) of
accumulated proteins, such as lubricin or proteoglycan 4
(PRG4), known as the lamina splendens.331,332 The superficial
zone accounts for a densely packed collagen II fiber network that
is organized in parallel to the articulating surface.333,334 Cartilage
of this zone has a low concentration of GAGs that allows for a
higher fluid flow.335−337 The intermediate zone (40−60% of the
cartilage thickness), bearing and dissipating most of the load
applied on cartilage, accounts for the characteristic arcade-like
collagen II fiber orientation.334 Here, the concentration of
GAGs is higher with very little fluid flow. The deep zone of
cartilage (20−50% of the cartilage thickness) is responsible for
transferring the loads to subchondral bone. Collagen II fibers
appear perpendicular to the underlying bone, and collagen X is
also present.334 The concentration of GAGs is maximal, allowing
for very little or no fluid flow.337 The ECM components
(collagen II and GAG concentrations) and the structure of the
different zones (arcade-like) are responsible for the strength and
pressurization of the tissue via entrapment of water molecules,
which together and in combination with permeability and
viscoelasticity result in a tissue with anisotropic and poro-
viscoelastic mechanical properties.337,338 Thus, articular carti-
lage accounts for an aggregate modulus of 0.08−2 MPa and a
Figure 10. (a) Cartilage and endochondral bone formation. 1 - Mesenchymal cells condense, proliferate and 2 - differentiate onto chondrocytes (c). 3 -
Chondrocytes at the center of condensation become hypertrophic (h). 4 - Perichondrial cells become osteoblasts and form the bone collar (bc).
Hypertrophic chondrocytes direct the formation of mineralized matrix, attract blood vessels, and undergo apoptosis. 5 - Osteoblasts of primary
spongiosa accompany vascular invasion, forming the primary spongiosa (ps). 6 - Chondrocytes continue to proliferate, lengthening the bone.
Osteoblasts of primary spongiosa are precursors of eventual trabecular bone; osteoblasts of bone collar become cortical bone. 7 - At the end of the bone,
the secondary ossification center (soc) forms through cycles of chondrocyte hypertrophy, vascular invasion, and osteoblast activity. The growth plate
below the secondary center of ossification forms orderly columns of proliferating chondrocytes (col). Haematopoietic marrow (hm) expands in
marrow space along with stromal cells. (b) Bioprinted cell laden hydrogels to create ear (1−6), meniscus (7−10), spinal disc (11), and nose (12, 13)
grafts. Scale bars = 5 mm, and the smallest divisions on the ruler are 1 mm. Reprinted by permission from refs 353 and 354. Copyright 2003 Springer
Nature and 2015 WILEY-VCH Verlag GmbH & Co. KGaA.
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Young’s modulus of 0.3−0.8 MPa in compression and 5−25
MPa in tension.339−344 The dynamic compressive Young’s
modulus of bovine articular cartilage has been reported to be as
high as 9.64 ± 1.81 MPa, as compared to the equilibrium
Young’s modulus of 0.64 ± 0.16 MPa.74 Similarly, a dynamic
compressive Young’s modulus of human articular cartilage of
around 4 MPa337has been reported as compared to approx-
imately 0.6 MPa in equilibrium conditions.345
The formation of articular cartilage starts when the
condensation of stem cells arising from the mesoderm
subsequently comes closer on the center of the condensate
and forms gap junctions and a dense structure parallel to the
bone anlagen.346 Here, the interzone develops as a morphoge-
netic process that will later give rise to the synovial joint. After
complete formation of the joint, the cartilage appears at the end
of still developing bones that together form the growth plate
(Figure 10a).347 The superficial zone is responsible for the
appositional growth of the tissue with chondrocytes that are
persistent and become only proliferative when they reach the
middle zone. Finally, the deep zone is responsible for the
formation of subchondral bone with chondrocytes that become
hypertrophic.
Due to its avascular character, the low concentration of cells,
and the intrinsic nonproliferative character, cartilage is unable to
self-heal or regenerate onto a functional tissue.324,329,348,349
Tissue engineering of non-load-bearing cartilage such as the
nose and ear has been successfully achieved (Table 4). The first
(andmost visual) results appeared two decades ago by Cao et al.,
who created an artificial ear by seeding bovine chondrocytes on a
nonwoven poly(glycolic acid) (PGA) mesh that was further
embedded in PLA by solvent-casting processes with an alginate
mold.350 The constructs were subcutaneously implanted into
athymic mice; after 12 weeks, they showed a gross histologic
appearance of neocartilage. Themain drawback of this study was
the need of a support material to avoid sample collapse during in
vivo implantation. Encouraged by these results, several groups
have attempted to tissue-engineer ear cartilage via AM
techniques. Poly(caprolactone) (PCL) provides good structural
properties and has been the most used in FDM or SLS to create
stable biodegradable scaffolds that were then seeded with cells
(either chondrocytes or stem cells) with or without the aid of
hydrogel materials such as collagen I.70,351 Recently, FDM-
generated PCL scaffolds have been exploited as the main
substrate in the first clinical application for auricular
reconstruction.352
Although these approaches are promising, the amount of cells
that can be encapsulated within the fabricated constructs is
limited to porosity and pore size. Thus, cell-based bioprinting
appears as an ideal technique. As mentioned earlier, the main
difficulties arise from the need of materials with good structural
stability and sufficient elasticity to allow repeated bending or
compression of the construct (Table 4). Alginate has been
widely used as a cell-encapsulating hydrogel for bioprinting
techniques. However, it lacks sufficient stability for this
particular application. In order to overcome this issue,
Markstedt et al. developed a novel bioink based on a
nanofibrillated cellulose−alginate composite that was used in
combination with human chondrocytes to produce ear-shaped
and meniscus-shaped scaffolds.93 These materials showed cell
viability after 7 days of culture, good printability and structure,
and mechanical properties that could be tuned from 50 to 250
kPa (compressive stiffness) depending on the cellulose weight
(%) loading. However, it is noteworthy that nanofibrillated T
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Figure 11. (a) Bone healing mechanism. The primary metabolic phases (anabolic and catabolic) of fracture healing are presented in the context of
three major biological stages (inflammatory, endochondral bone formation, and coupled remodeling) that encompass these phases. The primary cell
types that are found at each stage and the time span of their prevalence in each stage are denoted. Upon injury, specific-cell-mediated immune functions
remove necrotic tissues, promote angiogenesis, and initiate repair (0−3 days). Stem cells are recruited from the skeletal and vascular tissue, forming an
initial cartilaginous callus that is later vascularized (5−10 days). On the periphery of the callus, the periosteum swells initiating the primary bone
formation. Chondrocytes within the newly formed callus proliferate and differentiate, reaching hypertrophy (10−16 days). Hypertrophic
chondrocytes mineralize the existing matrix template and undergo apoptosis. After this initial phase, resorption and remodelling occur simultaneously,
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cellulose contains crystalline domains that require acidic
environments (or enzymatic processes) to degrade, rendering
the material biopersistent. In a very elegant study, Zenobi-Wong
and co-workers developed a bioink based on a combination of
clinically compliant biomaterials (all FDA approved for clinical
use) alginate, gellan gum, and cartilage ECM particles that could
be in situ cross-linked by coextrusion with a cation-loaded
polymer and a support bath containing mono- and divalent
cations.354 Bioprinting of the bioink together with cells proved
successful, yielding constructs with tensile mechanical proper-
ties of 116 kPa and high cell viability. The developed bioink was
used to create tissue-engineered ears, noses, menisci, and
intervertebral discs (Figure 10b). Although these constructs
show promise, different cartilaginous tissues account for
different biochemical and mechanical properties, which was
not taken into consideration in this first study.
Tissue engineering of load-bearing cartilage, i.e., articular
cartilage of the synovial joints, presents a more difficult challenge
due to the outstanding mechanical properties of its multizonal
structure. Thus, regeneration of these tissues requires significant
attention to the structure and mechanical properties of the
implanted materials. Traditionally, FDM techniques have used
polymer thermoplastics, such as PCL and PLA, which are stiff
and show poor resilience upon compression, unlike the
mechanical properties of native articular cartilage.355−360
Moreover, cell culture on these types of materials generally
results in cell morphologies that are not representative of
chondrocytes (spread vs rounded), promoting dedifferentiation
of the cells.361−363 In comparison, fabrication of hydrogel-based
scaffolds, where chondrogenic differentiation is more likely to
occur, results in mechanical properties that are rather low
compared to the native tissue. Thus, efforts have been focused
on the development of novel materials, or combinations thereof,
which result in scaffolds with adequate mechanical properties
while maintaining and promoting a chondrogenic phenotype
(Table 4). Kun-Che et al. developed water-born elastic and
biodegradable polyurethane nanoparticles based on PCL-diol
and polyethylene butylene adipate diol as soft segments and
isophorone diisocyanate as the hard segment, both used to
fabricate scaffolds via FDM.364,365 The resulting scaffolds
displayed a dynamic Young’s modulus of 0.4 MPa with a
shape recovery that ranged from 88 to 57% for 1−10% strain,
respectively. These materials induced aggregation of MSCs and
promoted chondrogenesis both in vitro and in vivo. However,
even if elastic in nature, articular cartilage is subjected to strains
of approximately 30% on a daily and cyclic basis and is capable of
recovering 100% of its initial shape after a long period of rest.366
In order to match the mechanical properties of articular
cartilage, traditional hydrogels such as GelMa, alginate, or the
thermoresponsive poly(PNIPAm) have been slowly substituted
by more complex polymer networks that aim at generating
scaffolds with a higher compressive modulus. In the last years,
Malda and co-workers have created an important library of
bioprintable hydrogel systems and combinations of bioprinted
hydrogels covalently attached to FDM thermoplasts to tackle
this issue.367−372 These include cell-laden microcarriers based
on PCL and encapsulated with GelMa-gellan gum bioinks and
two component hydrogels based on a thermoresponsive triblock
copolymer of PEG-NIPAm-HPMACys (N-(hydroxypropyl
methacrylamide) partially cross-linked to a PEG- or HA-
modified macromolecule and grafted to a thermoplastic
network, between others, with mechanical properties that are
on the order of hundreds of kPa. In this regard and similar to the
work described previously, Atala and co-workers developed an
integrated tissue-organ printer (ITOP) that allowed the
simultaneous deposition and modeling of several materials
within the same printer.373 By these means, they fabricated
hydrogel-based, thermoplast-supported scaffolds for the regen-
eration of various tissues such as cartilage, bone, and skeletal
muscle.
Another important approach to regenerate articular cartilage
is based on microfracture techniques that aim at the recruitment
of MSCs from the bone marrow, forming a clot on the damaged
area that should later be remodeled, prompted by the scaffold’s
material, into functional tissue. Thus, the designed scaffolds
need to fulfill the requirements of two different phases,
mimicking and promoting the formation of articular cartilage
in one phase or layer and the dramatically different underlying
subchondral bone.374,375 Gao et al. provided a good example of
this biphasic system and the required development of materials
with specific mechanical properties that can be printed onto
scaffolds mimicking the osteochondral interface.376 They
synthesized a high-strength supramolecular hydrogel based on
the copolymerization of two hydrogen-bonding materials: N-
acryloyl glycinamide and N-[tris(hydroxymethyl)methyl] acryl-
amide. The resulting copolymer is thermoresponsive and could
be deposited following sol−gel processes, reaching a compres-
sive strength of 8.4 MPa but a Young’s modulus of only 137 kPa
for the less porous hydrogels. Loading of the material with
transforming growth factor-β (TGF-β) on the cartilage-
mimicking phase and β-tricalcium phosphate on the deep
bone-mimicking phase resulted in materials with compressive
Young’s moduli of 16 and 23 kPa, respectively. The combination
of these onto a biphasic scaffold showed potential to regenerate
osteochondral defects on an in vivo rat model.
6.2. Bone
Bone is a hierarchically structured bioceramic composite
connective tissue forming the skeleton that confers structure,
Figure 11. continued
and secondary bone formation begins (16−21 days). Osteoclasts resorb the formed matrix template that, after being cleared by macrophages, is
remodelled by a differentiated osteoblast that will form the osteoid (21−35 days). (b) Schematic bone structure (1) and fabrication of bone mimetic
3D architecture containing osteogenic and vasculogenic niches. (2) A perfusable vascular lumen lined with HUVECs can be fabricated within a
pyramidal bioprinted construct by arranging individual rods of VEGF-functionalized GelMA bioinks with different mechanical strengths. The hMSC-
laden three outer layers of cylinders were loaded with silicate nanoparticles to induce osteogenic differentiation of hMSCs into bone tissue. The VEGF
was covalently conjugated into the three outer layers of the cylindrical hydrogels. The concentrations of conjugated VEGF were determined with
ELISA as 17.1, 34.2, and 68.5 ng mL−1. (3) Scheme of the 3D printing procedure of independent cell-laden cylinders using an automatized and
computer-controlled bioprinter. (4) Cross-section image of the pyramidal bioprinted construct. (5) Chemical conjugation of a gradient
sulforhodamine 101 (Texas Red) cadaverine onto −COOH-modified GelMA bioprinted fibers. The fluorescence intensity was directly proportional
to the conjugated amount of the fluorescent dye. Adapted with permission from refs 387 and 388. Copyright 2014 Springer Nature and 2017WILEY-
VCH Verlag GmbH & Co. KGaA.
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support, and organ protection while allowing for movement.
Bone is composed of 65% (wt) inorganic material, 25% (wt)
organic material, and 10% (wt) water. The inorganic component
of bone (bone apatite) is mainly HAp that appears as small
platelets of approximately 5 nm in thickness, 50 nm in width, and
100 nm in length, surrounding and infiltrating the collagen
fibrils.379−381 Apatite appears in a plethora of variations from its
stoichiometric ratio with ions from the physiological fluids
exchanging for any of its main components, PO4
3−, Ca2+, or
OH−.382,383 The organic phase of bone is primarily composed of
collagen I (>90 wt %) andminor amounts of glycoproteins, such
as alkaline phosphatase, fibronectin, osteopontin, osteoadherin,
and proteoglycans such as versican.384 It also contains minor
amounts of γ-glutamic-acid-containing proteins such as
osteocalcin and matrix gla protein. The inorganic and organic
components arrange into a very well-defined radial and
hierarchical structure. Collagen fibers, mineralized by nanosized
HAp, form fibril arrays that localize surrounding the blood
vessels on the Haversian channels, all together forming the
osteon. Osteons form the compact bone that appears to
cylindrically surround the trabecular or spongy bone (Figure
11a). Although compact bone and spongy bone are comprised
of the same components, they differ largely in their structure,
porosity (10% vs 50−90%, respectively), and mechanical
properties (the former ten times higher than the latter).382,385
Bones come in many shapes and sizes, and most of them (few
exceptions) arise from the endochondral ossification process.
Flat bones, such as the ones of the skull, are formed by direct
differentiation of clustered stem cells into osteoblasts, depositing
a collagen I-rich ECM via a process known as intramembranous
bone formation. Long bones, however, are formed after the
cartilage from the bone anlage. Hypertrophic chondrocytes of
the deep zone of cartilage are primarily responsible for bone
formation. They enlarge, direct mineralization, attract surround-
ing chondroclasts, and promote the differentiation of perochon-
drial cells into osteoblasts that form the bone collar and promote
vascularization, forming the primary spongiosa. After complet-
ing these essential functions, hypertrophic chondrocytes
undergo apoptosis, leaving a cartilaginous scaffold behind that
serves as a template for bone formation, the so-called growth
plate. Osteoblasts from the primary spongiosa will form
trabecular bone, and the bone collar will eventually become
cortical bone. This ossification process occurs in two distinct
centers (primary and secondary), giving rise to the long bones
(Figure 10).353,386
Bone is capable of self-healing upon fracture or when small
defects are to be bridged (generally considered as less than two
times the diameter of the affected bone).389,390 Upon fracture
and after an initial inflammation stage, bone healing occurs
similarly to the endochondral formation. Stem cells are recruited
from the skeletal and vascular tissue, forming an initial
cartilaginous callus that is later vascularized. The increase in
vascularization is reflected as an increased blood flow into the
damaged area. On the periphery of the callus, the periosteum
swells, initiating the primary bone formation. Chondrocytes
within the newly formed callus proliferate and differentiate,
reaching hypertrophy. Hypertrophic chondrocytes mineralize
the existing matrix template and undergo apoptosis. After this
initial phase, resorption and remodeling occur simultaneously,
and secondary bone formation begins.387 Osteoclasts resorb the
formed matrix template that, after being cleared by macro-
phages, is remodeled by differentiated osteoblasts, which will
form the osteoid. This coupled process continues until a balance
between the resorbed and remodeled matrix is reached (Figure
11b).391
However, bone is unable to successfully heal large defects
(critical size defects), which are currently treated using
autologous bone grafts, generally successful but complicated
by the limited availability and extra surgery steps. Thus, bone
regeneration or TERM appears as an attractive alternative to this
problem.392 Three main problems arise when TERM bone
replacements are conceived: (i) the scaffold material should
have high mechanical properties while being biodegradable and
porous (allowing for cell infiltration and newmatrix deposition);
(ii) the scaffold material should have a sophisticated hierarchical
structure to mimic that of the native tissue; and (iii) the need for
vascularization in such large tissue substitutes.393−396
In contrast to articular cartilage, bone regeneration strategies
have profited from traditional stiff materials such as cements,
ceramics, and metal alloys.397−401 The FDM of ceramic and/or
metal-reinforced polymers has proven successful in mimicking
the overall mechanical properties of the native tissue and, in
some examples, the structure.402−405 However, as explained
above, this technique has a limitation with the amount of cells
that can be successfully loaded within themanufactured scaffold.
Bioprinting of robust scaffolds that can reach the high
mechanical properties of bone and allow for vascularization
remains elusive due to the lack of adequate materials (Table 5).
Initial approaches to overcome this issue have focused on the
reinforcement of cell-laden hydrogels such as gellan gum with
more robust thermoplastic materials such as PCL using a
multicompartment approach.406 The work by De Giglio et al.
used porous interconnected PCL FDM scaffolds that were later
infiltrated with a gellan gum matrix loaded with either human
umbilical vein endothelial (HUVEC) or stem cells. Exploiting
their osteogenic properties, strontium ions were used as a cross-
linking agent and finally assembled within compartments of
different sizes. This multicompartment and cell coculture system
showed a high Young’s modulus of 135 MPa and a higher
osteogenic potential (alkaline phosphatase activity, osteopontin,
and osteocalcin expression) compared to the individual
materials and composite materials cross-linked with Ca2+ ions.
Following the approach of reinforcing hydrogel materials,
Keriquel et al. reported in situ laser-assisted bioprinting of
MSCs in vivo.407 The technique is based on a near-infrared
pulsed laser beam coupled to a scanning mirror and a focusing
system. A ribbon is used to spread the cell-laden bioink in which
the beam is focused. The energy generated creates a cavitation
bubble that will then propel a microdroplet containing the cell-
loaded hydrogel to the substrate of interest.408 In this particular
case, the authors used a bioink consisting of collagen I and nano
HAp bearing the MSCs that were in situ bioprinted onto a
calvaria-defect model in mice. This method provided spatial
control over the cell structure and localization, thus potentially
mimicking the native structure of bone and an improvement in
the bone formation after two months compared to non-
cellularized scaffolds.409,410 However, the produced materials
were still too thin to represent a mechanically robust system to
be further exploited.
In a more sophisticated model that mimics the hierarchical
structure of bone, Byambaa et al. reported the fabrication of
bioprinted scaffolds with osteogenic and vasculogenic patterns
(Figure 11b).388 The microstructured scaffolds consisted of a
cylindrical core of 5% (wt/vol) VEGF-GelMa loaded with
HUVECs and MSCs and three successive concentric layers of
10% (wt/vol) GelMa loaded with silicate nanoparticles and
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MSCs to induce osteogenesis. These last layers also contained
increasing concentrations of VEGF, aimed at promoting the
formation of a capillary network (Figure 11c). The soft core
allowed for a rapid (12 day) degradation, followed by cell
adhesion onto the formed inner cylinder that supported the
formation of a perfusable vessel-like lumen. The cells cocultured
on this lumen differentiated into smooth muscle cells, while the
MSCs encapsulated within the outer layer showed characteristic
markers of bone niches withmarkedly upregulation of collagen I,
osteocalcin, and osteopontin, among others.
A more realistic method to regenerate bone via bioprinting
techniques, with the current state of materials, is the
developmental approach. Such an approach consists in the
fabrication of scaffold materials capable of generating an initial
cartilage callus that can be later resorbed and remodeled into
bone tissue. In this regard, Chawla et al. fabricated MSC-laden,
silk-gelatin-based bioprinted scaffolds that were exposed to a 3
week chondrogenic differentiation step followed by a 2 week
differentiation in osteogenic conditions.411 Following this
approach, cell gene expression patterns that closely resembled
those found during in vivo endochondral bone formation were
observed, with initial expression of early markers of chondrocyte
hyperthrophy, such as RunX2 and collagen I, followed by
osteogenic markers such as alkaline phosphatase, osteopontin,
and osteocalcin and finally expression of osteocytic genes such as
podoplanin, dentin matrix acidic phosphoprotein-1, and
sclerostin. Although further studies would need to be developed,
with special attention paid to matrix deposition, mineralization,
remodeling, and final mechanical properties, this work
represents a very interesting approach to bone regeneration
via bioprinting techniques.
6.3. Blood Vessels
Blood vessels are fundamental in keeping tissues and organs
alive, by transporting nutrients and collecting waste metabolites.
Two distinctive processes can generate blood vessels: vasculo-
genesis and angiogenesis. Vasculogenesis occurs during
embryological development in the presence of no other blood
vessels, when progenitor endothelial cells (ECs) self-organize in
response to local biological cues (e.g., provided by growth
factors and ECM proteins) to form new blood vessels.
Angiogenesis occurs when blood vessels already exist: in this
case, new blood vessels stem out from the existing ones through
cell sprouting and the formation of new tubular structures, again
in response to local biological signals.412
Blood vessels are also organized in a vascular tree network,
decreasing in dimension from the heart to the periphery of the
body. Arteries bring blood from the heart to the periphery,
whereas veins collect blood from the periphery back to the heart.
Independent from their caliber, all vessels have an internal layer
of ECs, the endothelium, deposited on top of an ECM called the
basal membrane, which is typically comprised of collagen type
IV, laminins, and integrins. The smallest blood vessels in our
body, named capillaries, are characterized only by the
endothelium and the basal membrane. Large and mature
blood vessels have a more hierarchical structure comprised of
three additional ECM layers on top of the basal membrane,
called tunica intima (most internal layer), media, and adventitia
(most external layer). These layers are organized with collagen
fibers taking specific orientation (e.g., helical found in small
resistance arteries or herringbone found in large elastic arteries),
which contributes to the mechanical properties of blood
vessels.413 The ECM includes collagen type I fibers, which areT
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present through the vessel ECM but mostly abundant in the
external tunica adventitia layer. Collagen is mostly responsible
for the tensile stiffness of blood vessels. Elastin is also a crucial
ECM component and is still a challenging protein to be
synthesized during regeneration. Elastin is mostly present in the
tunica intima andmedia and can take various organizations (e.g.,
lamellae or fibers) depending on the vessel location and
mechanical function in the body. Elastin confers compliance and
combined with collagen prevents plastic deformation of the
vessels during pulsatile flow and regulates proliferation,
phenotypic modulation, and organization of vascular smooth
muscle cells. Other ECM proteins include collagen type III,
proteoglycans (e.g., GAGs), and glycoproteins (e.g., lectins).
Proteoglycans contribute to the compressibility of blood
vessels.414
Blood vessels vary in diameter from 1 to 2 cm to a fewmicrons
for capillaries. When approaching the fabrication of vessel
constructs, different biofabrication technologies415 could be
Figure 12. (a) Currently available fabrication technologies to create a branching vascular network. (b) An example of how hydrogels can be designed to
provide gel-in-gel bioprinting capabilities through host−guest interactions. Different endothelialized channels of variable complex architecture are
showcased. Adapted with permission from refs 415 and 418. Copyrights 2018 Elsevier Ltd. and 2018 WILEY-VCH Verlag GmbH & Co. KGaA.
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most optimally used for different dimension ranges (Figure 12a,
Table 6). One of the first bioprinting strategies to fabricate a
vessel was reported by Norotte et al., who used spheroids of
vascular and supporting cells of 300−500 μm that were
deposited next to each other onto an agarose-printed mold.
Due to the nonadhesive properties of agarose, the spheroids
fused, thus creating single or branched blood vessels.302 This
approach was followed by Tan et al.416 who used alginate instead
of agarose as a spheroid-fusing biomaterial bed and more
recently by Kucukgul et al.417 who returned to agarose and
developed an algorithm to bioprint large vessels with anatomical
fidelity to patient medical data sets. The use of low cell-adhesive
biomaterials such as alginate and agarose allows us to create
supporting beds that are ideal for spheroid fusion and further
tissue maturation during culture. However, these approaches
require a large amount of cells and long culturing times for tissue
maturation, thus resulting often in mechanically weak
constructs.
An alternative approach to spheroid bioprinting is to directly
embed cells into a hydrogel, thus processing such bioinks into
vascular-like structures. In order to choose the right hydrogel,
the capacity of cells to form tubular structures once embedded in
these biomaterials needs to be assessed. Benning et al.419
screened different commercially available hydrogels that are also
often used for bioprinting, namely, Matrigel, fibrin, collagen,
gelatin, agarose, Pluronic F-127, alginate, and alginate/gelatin
mixtures. Whereas gelatin was able to support the proliferation
of ECs, collagen and fibrin supported tubular formation.
Bioprinted EC spheroids in fibrin and collagen mixtures showed
also good viability and the capacity to sprout. Similarly,
Kreimendhal et al.420 showed that blends of agarose and
collagen type I could be promising bioinks for EC and fibroblast
mixture bioprinting, resulting in tubule formation and increased
storage modulus compared to collagen alone or blends of
agarose and fibrin. In a follow-up study, the same group
fabricated functional blood vessels replicating the tunica intima,
media, and adventitia organization by bioprinting ECs in gelatin,
smooth muscle cells in fibrin, and fibroblasts cast on top of the
bioprinted multilayer construct.421 These vessels showed
cellular reorganization and positive staining for VE-cadherin,
collagen type IV, and smooth muscle actin, as well as limited
permeability, thus confirming their biological functionality.
A hybrid approach between spheroid bioprinting and cell-
laden hydrogel bioprinting has been proposed by Skardal et
al.422 who co-cross-linked tetra(PEG) tetra-acrylate derivatives
with thiolated HA and gelatin and used this as a bioink to
encapsulate fibroblasts. Cell-laden filaments were then depos-
ited onto an agarose bed to form a vascular-like graft, which
showed cell viability for 4 weeks. Despite solving the limitation
of needing large cell quantities, this approach has not yet been
demonstrated with ECs, which limits its applicability. The
above-mentioned approaches show promising results in the
biofabrication of relatively large single vessels or vessels with
simple branching. Scaffolds with as small dimensions as vessels
bifurcating into capillaries have been successfully fabricated by
2PP using α,ω-poly(tetrahydrofuran-ether diacrylate), which
displayed fast fabrication kinetics and good mechanical
properties for small vessel grafts.423 Yet, true bioprinting
strategies incorporating ECs in such small vessels have yet to
be reported.
In the broader perspective of composite tissues, it would be
ideal to devise biofabrication strategies where a vascular network
can be directly incorporated into a second targeted tissue. This
would hold promise to create larger biological constructs if the
integrated vascular network can be perfused and can connect to
the host vasculature after implantation. In this direction,
Maiullari et al.167 used microfluidic bioprinting to create
different constructs to study the vascularization of cardiac
constructs. CMs were either alternated with ECs every 2 or 4
layers or deposited adjacent to each other in “Janus”-like fibers.
Cells were encapsulated in a mixture of alginate and PEG
monoacrylate fibrinogen, which was cross-linked by calcium
ions and UV exposure. Alginate was used only to provide shape
stability during bioprinting and later removed by chelating the
calcium ions. All constructs showed enhanced cardiac differ-
entiation in vitro and connected to the host vasculature after
implantation in mice, with Janus fibers outperforming the other
architecture in terms of vascular network organization. Similarly,
Byambaa et al.388 developed bioprinted vascularized bone
constructs, where GelMA with different degrees of methacryloyl
substitutions was used (Figure 11b). In particular, GelMA with
∼34% substitution was used to covalently bind vascular
endothelial growth factor (VEGF) and ECs, whereas GelMA
with 94% substitution was combined with silica nanoplates and
used to bioprint bone-marrow-derived MSCs that were induced
to differentiate into osteoblasts by the nanoplates. The different
degree of methacryloyl substitution resulted in a different
degradation rate, which induced the ECs to remodel the gel and
form a central vessel of 0.5 mm into the surrounding bone-like
constructs. To further explore the role of geometrical confine-
ment of cell-laden bioprinted hydrogels, Kang et al.424
developed a prefabricated cartridge that could be filled with
different cell−material formulations and used it in a proof-of-
concept study to demonstrate its versatility by combining ECs
with hepatic cells, which were encapsulated in either alginate or
collagen. Despite the authors showing several different complex
prefabricated shapes of the cartridges to be used for bioprinting,
this approach still has to reveal its full potential in creating
vascularized functional tissues.
An alternative, easy, and straightforward method to create
such vascular networks is to print a leachable biomaterial that
can be removed after embedding the printed network in a
desired cell-laden hydrogel. Miller et al. pioneered this approach
and showed that by using carbohydrate−glass it was possible to
create a relative simple network comprised of two primary
vessels of 1 mm in diameter connected by four secondary vessels
of 300 μm in diameter. Such a network was embedded in various
hydrogels including agarose, alginate, PEG, fibrin, and Matrigel
and showed to support EC adhesion and proliferation, thus
enabling endothelialization of the channels resulting from the
network dissolution. This resulted in enhanced survival and
functionality of hepatic cells embedded in the surrounding
hydrogel.425 When implanted, these constructs supported
physiological blood flow typical of the femoral artery and
showed connection with the host femoral artery in a rat animal
model.426 A similar approach was developed by Kolesky et al.,
who used bioprinting to create both the fugitive inks as well as
the bioinks to develop cell-laden constructs.317 As a fugitive
material, pluronic F-127 was used, whereas the bioprinted
construct was developed by blending gelatin and fibrin. A
vascular network as small as 200 μm could be created. This
resulted in the sustained culture of biological constructs larger
than 1 cm3 for more than 6 weeks and successful differentiation
of adult stem cells into bone cells (osteoblasts).427 Xu et al.428
also used Pluronic F-127 as a fugitive material, with
decellularized ECM (dECM) as a gel to encapsulate ECs,
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SMCs, and fibroblasts alone or in combination, thus creating
single vessels of diameters varying between 1.4 mm and 0.5 mm
with a tunica intima, media, and adventitia, respectively.
Alternatively, Bertassoni et al.318 elaborated a similar strategy
using agarose instead of Pluronic F-127 and demonstrated the
fabrication of vascular networks of more complex architecture
inside different hydrogels like GelMA, star poly(ethylene glycol-
co-lactide) acrylate (SPELA), PEG dimethacrylate (PEGDMA),
and PEG diacrylate (PEGDA). Pimentel et al.429 were able to
fabricate a branched vascular network with branching in both
horizontal and vertical planes with dimensions varying from 1.3
mm to 0.5 mm. The templating agent used was PVA coated with
PLA. The vascular tree was then incorporated in gelatin cross-
linked by transglutaminase in which hepatocytes were
Figure 13. Examples of coaxial fibers produced with core−shell nozzles: (a) vessels created with bioink composition with dual cross-linking (ionically
cross-linked alginate andUV covalently cross-linked acrylate 4-arm PEGwith GelMA) and (b) perfusable hollow fibers created with a coaxial extrusion
system combining GelMA, alginate, and 8-arm acrylate PEG. Adapted with permission from refs 431 and 432. Copyrights 2016 Elsevier Ltd. and 2018
WILEY-VCH Verlag GmbH & Co. KGaA.
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embedded at high density. The improved nutrient perfusion
resulted in supporting cell spheroid assembly with enhanced
oxygen diffusion. As in the work of Miller, the presence of a PLA
coating on the templating material could be beneficial for EC
Figure 14. (a) Schematic of the heart development showing the formation of the different compartments until the complete formation at day 50 and
(b) schematic of one of the approached investigated to produce cardiac patches and heart-like constructs. (c) 1 - 3D model of the heart construct; 2 -
bioprinting in a supporting bath of alginate microparticles; 3, 4 - printed constructs before and after bath removal (red and blue colored to show hollow
compartments divided by a septum area); 5 - confocal showingCMs and ECs; and 6, 7 - immunostaining sections of the bioprinted constructs. Adapted
with permission from refs 434 and 435. Copyrights 2000 Springer Nature and 2019 Noor et al. (published by WILEY-VCH Verlag GmbH & Co.
KGaA).
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adhesion and proliferation, although the thickness of such
coating should be carefully controlled to still allow nutrient
diffusion through the engineered construct. All the above-
mentioned templating approaches rely on different materials for
the cell-encapsulating and the templating compartments.
In a very elegant approach, Song et al.418 designed a dual
hydrogel strategy where HA was either modified with host−
guest chemistry (adamantine and cyclodextrin) alone or with
host−guest chemistry and norbornene-thiolene for further UV
cross-linking (Figure 12b). This dual system was then used to
create a 3D culture device where the host−guest-modified HA
could be used to pattern geometrically specific channels within
the dual cross-linked HA network by controlling degradation
(Figure 12b). This approach was then used to study
endothelialization and ECs sprouting in response to defined
vascular morphogenetic signals (e.g., VEGF).
Although these templating approaches have yielded promis-
ing results in terms of enhanced tissue nutrient perfusion,
maintenance of cell viability and functionality, and connection
to host vasculature, and thus should be definitely considered for
follow-up preclinical studies, the fabrication of branch-tree
networks with variable vessel diameter during processing proves
still difficult. A possible solution to the fabrication of such more
physiological vascular trees could be offered by coaxial
bioprinting, where branching could be promoted either by
incorporating and releasing angiogenetic factors or by changing
the diameter of the coaxial fibers during bioprinting by using
core−shell printing nozzles. Promising results in this direction
have been obtained by Akkineni et al.,430 who fabricated
implants made of hollow fibers with diameters ranging between
600 and 800 μm, with highly concentrated alginate as shell
material and alginate, chitosan, gellan gum, gelatin, and collagen
hydrogels as core materials. These hollow fibers were then
successfully covered by ECs, which adhered and proliferated in
the internal lumen. Fibers of different structural morphology
have been also created, by controlling the flow rate of core and
shell compartments, spanning from straight to wavy and helical
morphology.376 Jia et al.431 and Pi et al.432 moved this strategy
significantly forward with the fabrication of more intricate
networks of similar dimensions made of GelMA, alginate, and 4-
arm PEG-tetra-acrylate (PEGTA) or GelMA, alginate, and 8-
arm PEG acrylate with a tripentaerythritol core (Figure 13a,b).
The fabrication of these more versatile vascular networks was
enabled by combining microfluidic principles in the design of
the bioprinting cartridges and will certainly hold promise to
provide more control over the design of the vascular network
that can be created. However, the incorporation of these
networks with other tissues remains to be demonstrated.
Another possibility to fabricate a vascular network of different
dimensions (between 50 and 250 μm) has been shown by Zhu et
al.,433 who used DLP to create a vascular network of ECs
embedded in GelMA into a GelMA/HA blend containing
fibroblasts. ECs contained in such constructs were able to
reorganize the hydrogel network and form tubular networks,
which were shown to be functional in vitro and in vivo. A more
recent approach by the Miller group radically opened new
avenues to the fabrication of intricate and branched vascular
networks through DLP, using food dye additives as photo-
absorbers to pattern the vasculature within a hydrogel carrier
and showing functional oxygenation and vascularization in a
lung in vitromodel and in a murine hepatic animal model.55 The
fabrication of such intricate and branched complex vascular
networks certainly opens new doors to the biofabrication of
more physiological large-scale engineered tissues, although
vessel size reduction while branching and connection to
capillaries remain open challenges.
6.4. Heart
The heart is a highly compartmentalized organ that is
responsible for the continuous circulation of the blood
throughout the body. The generation of the heart and associated
circulation systems is the earliest events occurring during
development to support and promote the rapid growth of the
embryo. Both the heart and the great vessel system have to be
continuously remodeled at a very fast pace to support all the
necessary demands during and after gestation. The formation of
precardiac cells occurs frommesodermal cell precursors after the
migration of cells through the streak: cells that pass from the
primitive node, midstreak, and posterior streak form the outflow
tract, ventricles, and atria, respectively. These cells form the
cardiac crescent, which is stimulated with factors of the BMP
and FGF family by the endoderm inducing the heart formation,
and this process starts in the third week of gestation. After a
complex orchestration of the different cells, different heart
tissues are gradually formed, passing through different stages
over approximately 50 days until the aorta, left and right
ventricle, atrium, and arteries are formed (Figure 14a).434
A matured human heart is composed of an estimate of 9
billion cells between CMs, ECs, smooth muscle cells, fibroblasts,
and other connective tissue cells, immune cells, and other
specialized cells, with a variable turnover from birth to
adulthood.436,437 The ECM of the heart is highly dynamic,
and during the initial stages of heart development hyaluronans
are the main component of the cardiac jelly (acellular
component that separates the endocardium and myocardi-
um).438 Other ECM components that are formed during heart
development are fibronectin, fibrillin, proteoglycans, and
collagens type I, III, and IV, and these change after birth.438
Unbalances in ECM composition during development have
been associated with cardiac malformation (e.g., congenital
heart disease), highlighting the importance of the spatiotempo-
ral expression of its constituents tightly bound to cell migration,
reorganization, and ultimately differentiation.
6.4.1.Myocardium. In the case of myocardium, the tissue in
healthy conditions has as main ECM components glycoproteins,
proteoglycans, and GAGs and is populated by CMs,
myofibroblasts, ECs, pericytes, and immune cells.439,440 Upon
myocardium infarct induced by occlusion of coronary arteries,
tissue necrosis occurs, and significant reduction of contraction is
observed due to cell death. Upon cell death, a cascade of signals
triggers fibroblasts and other cells in the surrounding tissue to
repair the affected tissue, although only in mild cases this
regeneration occurs. Furthermore, significant changes on the
ECM level are observed upon invasion of the affected area by
macrophages and fibroblasts.440 Several TERM strategies are
currently under investigation to improve tissue repair or to
replace the affected tissue upon severe myocardium infarct
events.441−444 Acellular patches, cellular therapies, endogenous
repair, and combined strategies are themain groups of strategies.
Bioprinting has been used to develop myocardium patches
aimed for implantation on top of the affected tissue (Table
7).161,162,445−449 A cardiac patch to treat heart infarct ischemic
tissue was recently developed.446 The patches were manufac-
tured with pepsin-digested heart dECM.445,446 The ECM was
combined with human cardiac progenitor cells or hMSCs.446
The patches were produced by alternating bioinks in each layer,
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and the final constructs were composed of a PCL scaffold
support and up to 10 layers of bioink. The developed patches
were implanted in the epicardium of a myocardium-infarct
mouse model, and echocardiographic results showed that only
hMSC bioink patches that were supplemented with VEGF were
able to decrease dilation and increase contractile area.
LIFT was also used to produce myocardium patches for
potential infarcted patients.449 In this technique, gold-coated
slides were used as support for HUVECs and hMSCs that upon
irradiation with laser pulses were selectively transferred to the
target slide containing a porous polyester urethane urea film
coated withMatrigel. HUVECs were patterned in an orthogonal
grid, and squares of hMSCs were printed inside the grid. Patches
were implanted in an induced myocardial infarction rat model,
and results after 8 weeks showed improved cardiac function, wall
thickness, reduced fibrosis, and higher capillary density when
compared with control groups (untreated patch or patch with
randomly cultured cells).
Cardiac patches were also manufactured from cell spheroids,
composed of hiPSC-CMs, HUVECs, and human adult
ventricular cardiac fibroblasts, with an alternative pick and
place bioprinting system.161 In this approach, cell spheroids are
selectively placed in a needle array until fusion of the spheroids is
achieved. After removal from the needle array, the bioprinted
constructs were further matured and implanted in the heart of
rats. The implants integrated well in vivo, but further analyses are
required to understand the mechanical integrity of the printed
tissue and the application of nonmatured iPSC-derived CMs.
For bioprinting of other cardiac tissue, human fetal CM
progenitor cells were used in piston-driven bioprinting.447,448
Alginate with different concentrations and with or without RGD
was tested with progenitor cells.447 Similar constructs, including
progenitor cells, were further improved by being bioprinted with
a mixture of gelatin and HA bioink.448 Upon implantation in a
mouse myocardium infarct model, the cardiac parameters,
namely, end-diastolic and systolic volumes, were improved when
compared with the controls, and histological analysis showed a
thicker infarct wall and lower fibrotic tissue. Beijleri et al.450
investigated the combination of a cardiac progenitor isolated
from the right atrial tissue of pediatric patients and combined the
cells with gelMA or gelMA with decellularized and digested
porcine ventricular tissue ECM to form bioinks. Scaffolds were
bioprinted with a pressure-driven system and cultured in vitro
where the scaffolds containing the ECM-derived gel showed
improved gene expression of cardiac markers when compared
with gelMA-bioprinted scaffolds. An in vivo test performed by
implantation of the gelMA with ECM on the heart of rats
showed that the patch maintained the shape, and new blood
vessels invaded the patches, which were recovered after 14 days.
Further evaluation of the patches containing cells and relevant
disease models will be required to determine the suitability of
these patches for the treatment of affected myocardium tissue.
A multiphoton bioprinting laser-based system was recently
used to manufacture acellular myocardium scaffold patches
mimicking the native ECM by patterning GelMA with a
submicron resolution.451 These constructs were seeded with
hiPSC-CMs, smooth muscle cells, and ECs and implanted on
the myocardial infarction mouse model. Results showed
improved cardiac function on scaffolds seeded with cells when
compared to acellular scaffolds, but further understanding of the
integration of this implant requires additional testing.
For the development of a bioprinted full thickness
myocardium tissue, vascularization is essential for the viability
of the tissue upon implantation. Recently, a new strategy to
bioprint perfusable vascularized channels was developed by
manufacturing a mixture of alginate, GelMA, and acrylate PEG
printed through the shell channel of a coaxial nozzle and calcium
ions through the core to initiate alginate cross-linking. The
constructs were then further cross-linked by UV light exposure
after fabrication.431 Endothelialized myocardium tissue was
manufactured following a similar bioprinting strategy, by
manufacturing fibers containing ECs, bioprinted in a mixture
of GelMA and alginate, which migrated after bioprinting to the
periphery of the fibers,162 and by seeding CMs after maturation
of the vascular network. HUVECs formed a vascular lumen after
keeping the bioprinted tissue 15 days in culture. CMs seeded on
top of the constructs started beating after 48 h. Constructs were
further matured under perfusion in vitro in a custommicrofluidic
bioreactor, and cell viability improved when compared with
controls with no perfusion.
6.4.2. Heart Valves. Bioprinting heart valves is another
focus of cardiac tissue being investigated (Table 7).452,453 The
heart comprises four different valves, namely, the aortic (located
between the aorta and left ventricle), pulmonary (between the
right ventricle and pulmonary trunk), right or tricuspid, and left
or mitral atrioventricular valves (between the atria and
ventricles). These different heart valves have as their main
function the maintenance of unidirectional blood flow by
opening and closing in coordination with the heartbeat. The
valves are composed of a root section, a cartilage-like ring
(annulus fibrosa) connected to the heart muscle, and the leaflets
(right and left atrioventricular valves) or cusps (aortic and
pulmonary valves).454 While the annulus is mainly composed of
fibrous collagen, the leaflets and cusps are formed with a triple
layer arrangement termed fibrosa, spongiosa, and atrialis
(atrioventricular valves) or ventricularis (aortic and pulmonary
valves).454,455 The fibrosa layer is mainly composed of fibrillar
collagen type I and III; the spongiosa is composed of
proteoglycans with dispersed collagen fibers; and the atrialis
and ventricularis layers are mainly composed of elastin with
radial orientation. The valves aremainly composed of adult valve
interstitial cells located throughout the three ECM layers and
valvular ECs that form the superficial layer of the valves.455
Diseases such as aortic and mitral valve stenosis (closure or
deformation of the valve opening) and mitral regurgitation
(incomplete closure) are some of the most common valve
diseases with an increased prevalence in the elderly.456 In
children, congenital heart diseases and more specifically valve
diseases also have a high incidence. Synthetic or mechanical
heart valves surgically implanted are the only currently available
treatment for patients with affected valves, but failure of these
valves can occur due to infection, thrombosis, or even valve
failure (e.g., by calcification of leaflets).457 Furthermore, in
children a constant revision or replacement might be required
due to the growth of the valve size.458
Tissue-engineered approaches have been developed to
manufacture heart valves spanning from decellularized scaffolds
from allogenic or xenogenic source valves, scaffolds manufac-
tured by electrospinning or molding techniques, and bioprint-
ing.459 Duan et al. used bioprinting to manufacture heart valves
by combining alginate and gelatin with porcine aortic valve
interstitial cells or human aortic root smooth muscle cells.453 A
3D model of porcine aortic valves was created with a micro-CT
image data set, and this model was used to manufacture the
constructs. Smooth muscle cells combined with the hydrogel
mixture were used to print the valve root, and interstitial cells
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were used to print the valve leaflets. Live/dead assays showed
that the bioprinted valves had a high cell viability (81−83%) for
both populations of cells. In a follow-up study, the same group
used methacrylate HA and GelMa with human aortic valvular
interstitial cells.452 The constructs were cross-linked under UV
and placed in culture for 7 days. Results showed new collagen
and GAG deposition. Despite this initial result, no functionality
test on the bioprinted valves was performed, and longer cell
culture experiments with more extensive characterization were
required before having a valve ready for in vivo testing.
6.4.3. Future Outlook for Bioprinting Cardiac Tissue.
These achievements have been focused on the development of
cardiac patches for infarcted myocardium as a deliverable
mechanism of cells and an ECM-like supporting matrix for the
regeneration of the affected tissue. These bioprinted cardiac
tissues are rather simplified when compared to the native
counterparts, and only some of the bioprinted tissues were
tested in vivo. Some preliminary in vivo validation in small animal
models of the different bioprinted constructs showed promising
results, although these are probably insufficient if evaluated on
large-size animals. The regeneration of the thin myocardium of
small animal models might be easier due to the low thickness of
the tissue and to the low demands of vascularization. So far, only
morphological embryonic heart-like scaffolds have been
bioprinted.51 A chicken embryonic heart was fixed and stained,
and a stack of fluorescent images allowed the generation of a 3D
Figure 15. (a) Renal development starts from two populations of progenitors. After several events, the branching starts to occur with the formation of
the nephron filtration units. (b) Kidney physiology: one million nephron units, and each nephron is compartmentalized where filtration occurs while
urine is produced. (c) and (d) Examples of bioprinting studies where convoluted channels have been produced with sacrificial 3D printing and
postseeded with renal epithelial and ECs. Adapted with permission for refs 469, 470, 474, and 475. Copyrights 2002 Springer Nature, 2018, Springer
Nature, 2019 Lin et al. (published by National Academy of Sciences), and 2016 Homan et al. (published by Springer Nature).
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model containing the outer and inner morphology. In order to
be printed, themodel was scaled up tomatch printing resolution,
and no cells were included. In a recent study, Noor et al. also
demonstrated in a proof-of-concept study that a heart-like
structure could be produced with two cell (CMs and ECs)
populations on omentum dECM bioinks that were selectively
dispensed on a supporting bath containing alginate micro-
particles with medium supplemented with xanthan gum (Figure
14b,c).435 Similarly, Lee et al. also demonstrated the
manufacturing of a heart valve and heart-like constructs where
a supporting bath was essential to maintain the geometrical
shape of 20 μm collagen-based filaments.54 These examples of
heart-like models provide essential insights that much more is
needed both at the cellular but also at the biomaterial-ink
composition levels to make a full-size functional organ.
Furthermore, the levels of function and maturity are yet to be
demonstrated.
When envisioning human myocardium regeneration, a simple
scale up of the bioprinted constructs might not be enough, and
the inclusion of vasculature might be essential. Another point of
consideration is the choice of cells that can be expanded in
sufficient numbers to create large size tissue constructs. PSCs
might be a promising alternative, but maturity and function
should be ensured.460 Several protocols have already been
established to generate cardiovascular progenitors.461,462
Perfusion and vascularization are also essential to keep tissue
viable in vitro, while maturation occurs and upon implantation
and during regeneration. Another point normally not discussed
is that the designed tissue implants of the modulation require
integration and regeneration while avoiding immune reaction.
Similarly, these and many more unknowns should be considered
for the bioprinting of a full heart, and there is still a long road
until achieving a full functional health for replacement therapy.
6.5. Kidneys
The kidneys are complex organs that continuously filter the
blood while maintaining homeostasis and waste excretion
functions. These functions involve the regulation of osmolality,
volume, acid−base status, and ionic composition of the body
fluids, as well as removal of metabolic byproducts out of blood
circulation.463 Moreover, kidneys produce hormones such as
calcitriol, erythropoietin, and renin, which have an effect on
calcium metabolism, erythropoiesis, and systemic blood
pressure, respectively.464
The kidney development derives from the formation of the
intermediate mesoderm from the mesoderm layer. Three types
of kidneys are initially developed, namely, the pronephros,
mesonephros, and metanephros. The two initial structures are
temporary and with limited or no known function, and the
kidneys are only formed from the metanephros.465 The
formation of the kidney starts by the two distinct cell
populations derived from the intermediate mesoderm, the
metanephric mesenchyme (MM), and ureteric bud (UB) cells
(outgrown from the Wolffian duct) (Figure 15a). Upon the
cross contact of these two progenitor cells, a process termed
branch morphogenesis (formation of the ureteric tree) occurs
followed by differentiation of the MM cells that condense and
segregate to cap mesenchyme and renal stromal cells, and these
start to form structures such as renal vesicles (initial epithelial
structure) that initiate the development of the nephron
structure.465 The process of development continues with the
glomerulus structure where ECs, mesangial cells, podocytes, and
epithelial cells form a complex filtration unit where the
formation of filtrate from blood flow starts.466 Each nephron
consists of a renal corpuscle and a sequence of specialized
tubules, including the proximal tubule, loop of Henle, distal
tubule, and collecting duct (Figure 15b).463 This highly
compartmentalized filtration unit has more than 20 different
cell types distributed in successive sections with distinct
functions. Blood is brought to the renal corpuscle by a network
of capillaries that form the glomerulus surrounded by the
Bowman’s capsule. Solutes below the molecular size of albumin
(68 kDa) pass the glomerular filter and constitute the primary
urine, which travels through the nephron tubule sections where
essential components present in the filtrate are reabsorbed until
the final urine is then excreted through the collecting duct. The
development of nephrons in humans terminates after birth, and
the number of these units varies in a human organ from 200
thousand to 2 million.465
Kidney ECM and renal basement membrane compositions
change during development, during maturity, and in patho-
logical conditions.467 The main ECM components found in the
kidney basement membrane are collagen type IV, laminins,
sulfated proteoglycans, and entacin/nidogen.467 The different
sections of the nephron have variable compositions of the
basement membrane, revealing the complexity of the extrac-
ellular composition. Recently, Nagao et al. characterized and
quantified human kidney cortex tissue with chromatography and
mass spectroscopy.468 The obtained results showed that the
cortex tissue is composed of collagen type IV (37%), collagen
type I (20%), laminin (8.6%), heparan sulfate proteoglycans
(3%), fibrilin-1 (2.8%), and many others.
Chronic kidney disease (CKD) is an increasing health and
societal problem, resulting in loss of kidney function in patients,
ultimately requiring organ transplant. It is estimated that 10% of
the world population is affected by CKD. Critical organ shortage
makes extended duration of dialysis inevitable, thus leading to
morbidity. Hence, there is an urgent need for novel therapies.
Upcoming regenerative approaches develop into two directions:
first, the endogenous repair and alleviation of renal disease
progression, and second, the provision of transplantable organs
or functional organ units. For both approaches, fundamental
challenges must be addressed, and in vitro 3D models capable of
simulating kidney functions will allow better understanding of
the different regeneration strategies. Bioprinting can be an
essential asset to create such 3D models to investigate renal
development, disease, and regeneration in vitro while allowing
new knowledge that can be essential for full organ manufactur-
ing.
6.5.1. Renal Bioprinting. Due to the complexity of the
kidney and the nephron, only simplifications of the nephron
focusing on specific sections have been designed and
manufactured by bioprinting (Table 8). These bioprinted
models have been mainly developed for drug toxicity screening,
but these could also be envisioned to study for instance
regeneration post injury. A proximal tubule-like segment of the
nephron was bioprinted in a hybrid approach combined with a
perfusable chip (Figure 15c,d).469−471 Perfusable channels were
prepared by depositing a sacrificial ink (pluronic), connecting
the inlet and outlet ports of a PDMS-printed chip. After removal
of the sacrificial material previously encapsulated inside a casted
hydrogel composed of gelatin and fibrin, the chips were seeded
by perfusion of immortalized human proximal tubular epithelial
cells (PTECs). With this approach, the direct bioprinting of cells
was avoided. The PTECs cultured on the chips were left to
mature for up to two months, and nephrotoxicity with a known
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compound was tested. Results showed that the epithelial layer
was gradually disrupted in correlation with the dose of
nephrotoxin used. A follow-up study by Lin et al.470 used the
same approach to produce two parallel channels where one
channel was seeded with glomerular microvascular ECs and the
adjacent channel with PTECs (Figure 15d). Transport
reabsorption function between the adjacent tubules was tested
with fluorescently labeled human albumin and inulin. Results
showed that inulin was retained in the epithelial compartment,
while the albumin was reabsorbed.
Organovo developed recently a similar proximal tubule-like
tissue bioprinted in a transwell membrane.472 In this case and in
Figure 16. Liver: (a) schematic representation of the liver lobule sections showing a complex cellular organization radiating from the central vein and
surrounded by hepatic artery, portal vein, and bile duct. (b) Schematic representation of a DLP-based bioprinting approach tomanufacture liver lobule
models. (c) Bioprinted construct on a round coverslip. (d) Confocal microscopy image and 3D reconstruction of the bioprinted tissue with hepatic
cells stained in green and HUVECs and ADSCs used as support cells stained in red (scale bar 500 μm). Adapted with permission from refs 34 and 485.
Copyright 2016 Ma et al. (published by National Academy of Sciences) and 2006 Springer Nature.
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contrast with the approach designed by Homan et al., fibroblasts
and HUVECs were mixed with a proprietary thermoresponsive
hydrogel and bioprinted in a layered structure. After 3 days in
culture, renal PTECs were seeded on top of the bioprinted
layers. After maturation, the tissue showed microvascular
networks, tight junction, and polarization of the renal cells.
Nephrotoxicity was also tested on the mature tissue with
cisplatin, a known nephrotoxic drug. Results of clinically relevant
concentrations and dosage of cisplatin showed a detrimental
effect on cell metabolism and cell viability with increased drug
concentrations.
The bioprinting approaches developed have mainly focused
on the development of in vitro tissue models that could be used
to screen drugs. These specific bioprinted nephron sections are a
small portion of the full nephron structure and function, and
further models are necessary to understand what is needed to
manufacture a better mimicking nephron functional unit. Recent
achievements such as the ones that allow the generation of
nephron organoids149,151 might be difficult to achieve in the near
term with bioprinting due to the resolution limitations, lack of
suitable cells, and suitable bioinks that allow a furthermaturation
and rearrangement of tissue. For this reason, more research
should be oriented at understanding which bioprintable
hydrogel facilitates organogenesis and tubulogenesis in vitro.
PEG-based hydrogels were used to evaluate tubulogenesis
formation of renal cell lines or primary human renal proximal
tubule epithelial cells.473 In this work, heparin and matrix
metalloproteinase (MMP) cleavable chains were added to the
hydrogel preparation, and tubulogenesis was more evident when
compared with nondegradable (MMP-free) or heparin-free
hydrogels. Nephrotoxicity of the tubular structure was tested by
incubating the 3D cultures with different concentrations of
cisplastin for 48 h. Furthermore, the transepithelial transport
functionality of the tubular structure showed cells with
functional anion transporter due to the presence of luciferase
yellow inside the tubules even after long washing periods. In a
recent example, organoids have also been coupled with printing
techniques to investigate the vascularization of previously
formed renal organoids.471 Despite that this study only made
use of 3D printing to build a perfusion chamber to encase the
prevascularized bed and the manually dispensed organoids, a
similar approach could be envisioned with bioprinting for both
the vasculature bed and the organoids. In this study, it was
shown that a preformed vascular bed and controlled flow are
important for further maturation and vascularization of
previously formed organoids.
In addition to the kidney, another tissue from the urinary
system that has been manufactured by bioprinting is the
urethra.476 Scaffolds were prepared in a pressure-based bio-
printer equipped with three dispensing heads: one for the
deposition of a support tubular construct manufactured with
PCL or/and combinations of PCL and poly(lactide-co-
caprolactone) (PLCL) and two other cartridges to dispense
the bioinks. Two bioinks were prepared by combining
fibrinogen, gelatin, and HA with rabbit autologous cells
(urothelial cells and smooth muscle cells). The thermoplastic
polymer was deposited first in a tubular form. Next, two tubular
layers of urothelial cells and three tubular layers with smooth
muscle cells were deposited concentrically on the inside and
outside of the polymer, respectively. Cell viability was above
93% after 1 day and 75% after 7 days in culture. Further in vivo
validation will be required to evaluate this bioprinted urethra
construct.
6.5.2. Outlook Kidney Bioprinting. The ambition of
bioprinting a full kidney might still be decades away from being
possible. Several challenges need to be addressed before the
complexity of the structures that can be bioprinted can mimic
with some extent the multitude of functions of the kidney
filtration unit. The challenges persist on all aspects spanning
from the cells that should be used for the bioprinting to the
biomaterials used for the bioink formulations. Regarding cell
source, the new development of kidney organoids might allow
the production of a multitude of predifferentiated cells that
could allow researchers to produce constructs with relevant cells
that can be found in the human organs.150,152 These organoids
are self-assembled constructs, and the same organogenesis
identified in these 3D models might not be possible to achieve
with current bioprinting techniques, as further control on single-
cell bioprinting would be required. Furthermore, one could
argue if it is necessary to place accurately the cells in known
positions or if cellular rearrangement is possible postbioprinting.
Dispensing the multitude of different cells would also require a
multiprint head system capable of individually dispensing each
cell type. Another important topic that will require extensive
research is the development of suitable bioinks. In a recent study
performed by Sebinger et al., multiple ECM molecules and
growth factors were screened with kidney rudiments, and results
showed remarkable changes on the development on kidney
organoid rudiments in vitro.477 This shows that an accurate
selection and control of the deposition of the ECMmolecules of
choice could dictate the success of the bioprinted organ. Other
points such as maturation conditions in vitro with the use of
custom developed bioreactors should also be taken into
consideration and will certainly be a point of future research.
7. ENDODERM
The endoderm germ layer gives rise to tissues such as thyroid,
liver, pancreas, lung, thymus, and the gastrointestinal tract.
Initial development on the bioprinting of liver functional units
and pancreatic tissue implants is covered in the following
sections.
7.1. Liver
Liver is the largest organ in the human body, weighing an
average of 1.4 kg. It consists of a large right lobe and a small left
lobe separated by a band of connective tissue, which anchors the
liver to the abdominal cavity. The tissue is made up of hexagonal
units, called lobules, mainly constituted of hepatocytes (Figure
16a). Many blood vessels and bile ducts run between the liver
cells. The portal vein brings the blood from the digestive organs,
carrying nutrients and also toxic substances. Once they reach the
liver, these substances are processed, stored, altered, detoxified,
and passed back into the blood or released in the bowel to be
eliminated, such as alcohol and byproducts of medication. The
liver is also involved in the metabolism of fats, carbohydrates,
and proteins. Fat metabolism takes place by β-oxidation and is
converted to energy by hepatocytes. By carbohydrate metabo-
lism, the liver maintains the sugar balance in the blood. Excess
sugar in the blood is converted into glycogen in the liver. In the
case of low blood sugar, the glycogen stored in the liver cells is
broken down and released into the blood. For protein
metabolism, liver cells metabolize the amino acids from proteins
to synthesize carbohydrates and fat. The toxic byproduct in the
form of ammonia is converted into urea and released into the
blood, which is filtered in the kidney and excreted through the
urine.
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The liver has a central portal vein with radially distributed bile
ducts, portal venules, and arterioles, all connected by a network
of channels called sinusoids. The sinusoids are formed by ECs
and Kupffer cells and are surrounded by hepatocytes and stellate
cells. Kupffer cells are macrophages responsible for the removal
of toxic substances and pathogens, while the hepatocytes are
responsible for detoxification, lipid and carbohydrate metabo-
lism, and protein synthesis. Liver stellate cells, whose complete
function is not fully known, are quiescent cells triggered by liver
damage and responsible for scar tissue formation.
The liver has remarkable regeneration capacity when hepatic
resection is performed.479 However, this regenerating capacity is
impaired when continuous damage is induced and/or acquired
or there are congenital diseases. The reasons for this diminished
capacity are not yet fully understood; however, inmost cases, the
presence of highly fibrotic and scarred tissue leads ultimately to
liver failure, and a transplant is required.
7.1.1. Liver Bioprinting. The possibility of creating
bioprinted liver tissue patches is being pursued by several
research groups, which aim at mimicking native healthy or
pathological tissues in vitro and ultimately implantable tissues for
regenerativemedicine applications (Table 9). In vitromodels are
also envisioned as a suitable platform for drug screening and
development.480,481 Most attempts to create liver-like tissue
have used cell lines46,482,483 as the main cellular constituent.
Only recently, PSCs34,484 have been used in bioprinted liver
constructs. Faulkner-Jones et al. reported bioprinted hiPSCs and
hESCs that were differentiated toward hepatocyte-like cells.484
Droplet-on-demand, electromechanical valve-bioprinting heads
were used to selectively dispense hydrogel droplets and ionic
cross-linking solution. Layers created by the dispensed droplets
of alginate were subsequently cross-linked by dispensing
droplets of calcium ions, and constructs with 20 and 40 layers
were manufactured. Albumin secretion was used as a readout to
understand the differentiation and function of the bioprinted
hepatocyte-like cells encapsulated in alginate constructs. Results
showed reduced albumin secretion from bioprinted cells when
compared with the 2D controls.
The need for vascularization in liver is an important aspect
that should be strongly considered. Initial approaches have
combined ECs with primary hepatic cells to develop a
bioprinted liver model.480 In this approach, multicellular
constructs composed of primary hepatocytes, hepatic stellates,
and HUVECs were bioprinted with NovoGel. The 3D models
manufactured did not mimic exactly the liver morphology, but
the presence of a vascular network shows that the combination
of essential cells such as ECs could improve the produced
models. The produced liver models were tested with a
hepatotoxic drug, and results matched those reported clinically.
The level of complexity of this bioprinted liver model showed to
be a step closer to native tissue with comparable lipid and
glycogen storage and vimentin patterning expression. However,
since the construct was envisioned as an in vitro model, it
requires further validation if the aim is to be used for tissue
regeneration.
Perfusion is an essential aspect that needs to be taken into
consideration to mimic the culture conditions in vitro as close as
possible to the native organ. For this, a recent approach was
developed by combining a PDMS microfluidic chip or
microbioreactor with an array of bioprinted GelMA droplets
encapsulating HepG2 aggregates.481 Hepatic biomarkers were
measured in themedium supernatant. A dose−response study of
a hepatotoxic compound was also tested on static culture
conditions. Albumin, alpha-1 antitrypsin, transferrin, and
ceruloplasmin secretion showed that the constructs remained
functional up to 30 days in culture. Similarly, a liver organ-on-a-
chip manufactured with bioprinting, where the chamber and the
cell bioprinting (HepG2 and HUVECs) were performed in a
single step, was recently investigated.483 Different configurations
of cells and hydrogels have been deposited inside a PCL
chamber. The liver model was composed of a bottom layer of
HepG2 cells encapsulated in collagen and a top layer of ECs
encapsulated in gelatin. After incubation, the gelatin dissolved,
leaving a cavity that allowed medium perfusion. Urea and
albumin secretions were quantified during the 6 days of cell
culture period. Results showed an improvement of the secretion
on static coculture conditions and an additional improvement
with the addition of perfusion when compared to nonperfused
hepatocyte conditions.
Ma et al. recently used a stereolithograhy bioprinting
approach to manufacture scaffolds mimicking the hepatic lobule
microarchitecture (Figure 16b−d).34 Hepatic progenitors cells
(HPCs) derived from hiPSCs were bioprinted either alone or in
combination with HUVECs and adipose-derived stem cells. An
increase in cell cluster size, gene expression, cytochrome P450
induction, and metabolite secretion was observed on the
triculture models when compared to HPCs alone.
DECM has also been used as a suitable bioink for liver
bioprinting, due to the presence of essential growth factors and
proteins such as collagen, elastin, and GAGs. Skardal et al.486
investigated the combination of HA and gelatin-based hydrogels
with liver dECM and bioprinted with previously prepared
spheroids composed of primary human hepatocytes, stellate
cells, and Kupffer cells. The spheroids bioprinted with hydrogel
containing dECM were more viable when compared with
bioprinted gelatin constructs. Urea and albumin were secreted
from the bioprinted constructs throughout the 14 days of
culture.
7.1.2. Outlook on Liver Bioprinting. Similarly to the
previously covered organs, themanufacturing of a full livermight
still require decades of research. Despite the innate regenerative
capacity of the liver, in some pathological cases a full bioprinted
organ might be a suitable alternative to donor organs. As with
other organs, multiple cell lines have been initially used in proof-
of-concept studies, but gradually the inclusion of more relevant
PSCs has also started to be reported. Furthermore, PSC
differentiation protocols have also been established.487 Minimal
functions have already been demonstrated in some of the
bioprinted models (e.g., albumin secretion), but other functions
performed by the liver might only be possible as the models
become gradually more complex and more representative. The
availability of liver in vitro models is highly interesting for
pharmaceutical companies to perform preclinical toxicity and
metabolite screenings as alternatives to currently performed in
vivo or 2D cultures.488 This gradual adoption of these
alternatives might provide a further development of such
bioprinted models that will facilitate further knowledge essential
to build a fully functional liver.
7.2. Pancreas
The pancreas has two main functions in the human body, the
production and release of digestive enzymes (exocrine function)
and the production of hormones such as insulin and glucagon to
regulate blood sugar levels (endocrine function). The pancreas
develops from the embryonic posterior foregut, emerging as a
bud from the dorsal and ventral sides of the gut tube, formed
Chemical Reviews pubs.acs.org/CR Review
https://dx.doi.org/10.1021/acs.chemrev.9b00789
Chem. Rev. XXXX, XXX, XXX−XXX
AP
following the folding of the definitive endoderm. The early
specification of the pancreatic anlage is mediated by retinoic
signaling and by inhibition of hedgehog signaling.489,490 The
endocrine specification takes place in some of the pancreatic
progenitor cells upon inhibition of Notch signaling, activating
transcription factors for endocrine cell differentiation.491,492
Following the migration of endocrine progenitors in the
surrounding mesenchyme, they rearrange into islands of
specialized cell types called islets of Langerhans, named after
the German pathologist who discovered them in 1869.493 These
islets compromise five endocrine cell types, namely α, β, δ, PP,
and ε cells, which produce glucagon, insulin, somatostatin,
pancreatic polypeptide, and ghrelin hormones, respectively
(Figure 17a). Endodermal cell differentiation through exocrine
and endocrine signaling induces insulin-secreting cells as early as
4 months of gestation, with a final mature islet cell mass
achieving a diameter of approximately 150 μm.
Traditionally, two types of diabetes have been classified,
although a recent suggestion proposed five distinct types.494
These all affect a patient’s ability to control blood sugar level and
the ability of insulin to trigger the body to take up glucose. Type
1 diabetes (T1D) is the result of a reduction of pancreas β-cell
mass caused by an autoimmune response, impairing insulin
secretion and leading to hyperglycemia. In contrast, type 2
diabetes (T2D) is generally characterized by a limited
autoimmune response but still exhibits β-cell loss and, in
addition, the onset of insulin resistance that prevents the body
from taking up glucose and, therefore, leading to hyperglycemia.
While T2D can be often mitigated through diet, exercise, and
lifestyle, T1D patients rely on daily insulin injections to control
blood glucose levels. Therapies such as islet transplantation have
been tested as an alternative treatment, and phase 3 clinical trials
showed that 87.5% of the treated patients showed glycemic
control after 1 year.495 Despite the positive results, these patients
must take immunosuppression therapy, triggering potential
adverse effects such as renal dysfunction, and long-term insulin
independence often cannot be maintained.496
7.2.1. Pancreas Bioprinting.Most bioprinting efforts with
respect to TERM of the pancreas have focused on creating a
construct to facilitate implantation of allogenic islet cells (Table
10). While the implant of islets of Langerhans and its cellular
constituents is a highly promising diabetes therapy, many
Figure 17. Pancreas: (a) simplified schematic representing the endocrine cellular composition (insulin-secreting β cells and glucagon-secreting α cells)
and exocrine cellular composition (95% of the total tissue composed of acinar cells responsible for the production of digestive enzymes and network
duct cells that facilitate transport of enzymes to the intestine) of the pancreatic tissue. (b) Schematic representation of piston-driven bioprinting
approach to manufacture islet encapsulating implants. (c and d) Manufactured implants showing cell viability up to 7 days. Adapted with permission
from refs 498 and 499. Copyrights 2017 Springer Nature and 2015 IOP Publishing, Ltd.
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challenges remain in order for this approach to successfully
return lost endocrine functionality.497 Critical considerations
targeted by the bioprinting approach include cell viability during
processing, the maintenance of islet function (e.g., insulin
release), and the long-term survival of the islet mass by limiting
the immune response toward the implanted cells while ensuring
sufficient nutrient supply.
To prevent immune cell interaction with transplanted islets,
several bioprinted carriers are currently under investigation.
Marchioli et al.498 developed a bioprinted scaffold from alginate
or alginate in combination with gelatin, HA, or matrigel for islet
implantation (Figure 17b−d). The islet carrier scaffold showed
good cellular viability both in vitro and in vivo, but the metabolic
activity was reduced likely due to the small mesh size of the
hydrogels used for bioprinting. Glucose and lactate concen-
trations quantified throughout the cell culture period were
similar for all the encapsulated islet conditions. Glucose
stimulation to test insulin release from the islets showed
reduced function when β-cells or human islets were bioprinted,
while islets retrieved from the bioprinted constructs showed a
return of stimulated insulin release. This suggests that an
optimization of the hydrogel composition to allow insulin
release might improve the performance of the bioprinted
construct.
Toward this goal, Duin et al.500 employed a bioink comprised
of alginate and methylcellulose (MC), with the latter improving
printability of the alginate filaments and microporosity.501
Significant improvements were observed for insulin diffusion
through alginate/MC scaffolds compared to scaffolds made
from alginate alone; however, bioprinted islets were smaller and
more fragmented, had reduced viability, and were more
apoptotic compared to free-floating control islets.500 Overall,
this is reflected in the analysis of islet function, with bioprinted
islets cultured in vitro for 4 days achieving appreciable insulin
release in response to glucose stimulation but then losing
function by day 7.
Liu et al.502 recently reported a customized coaxial bioprinting
approach capable of printing core/shell filaments with an islet-
rich core surrounded by an outer-shell layer. Using a customized
cooling print head and an alginate/GelMA composite bioink,
the outer shell is intended to better protect the islet and also used
to deliver a surrounding layer of support cells; these include ECs
to improve islet engraftment into the host tissue and T
regulatory cells to reduce the immune response. While this
approach resulted in viable bioprinted islets, the functional
release of insulin was again diminished with the reduced
diffusion of insulin cited as a probable cause.
In addition to functional units and islets carriers, bioprinting
has been used to develop pancreatic disease models.503 Tumor
models were bioprinted by depositing two bioinks: one
containing pancreatic stellate cells and ECs and the tumor
bioink with pancreatic cancer with different combinations.
7.2.2. Outlook of Pancreas Bioprinting. Similar to other
organs, the bioprinting of the full pancreas is in its infancy, and
much more research is required until it becomes a realistic
possibility. The preliminary work performed on bioprinting
specific cell types or entire islets of Langerhans indicates so far
that constructs do not achieve the same functionality as the
native organ. Future work will certainly focus on the develop-
ment of appropriate hydrogels to allow insulin diffusion from the
constructs. Furthermore, vascularization strategies will continue
to be a focus of researchers to ensure the nutrient supply for islet
viability and to improve the systemic release of insulin from theT
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implanted construct. Patient-derived PSC-derived β cells might
be a future asset in terms of bioprinting implants and the full
pancreas as a syngeneic cell source that has been shown to
secrete insulin504 and even reverse diabetes in animal models.505
8. OTHER BIOPRINTED TISSUE
8.1. Glands
The very first example of bioprinting applied to a gland is for the
regeneration of sweat glands, which play an important role in
thermoregulation. Huang et al.506 used a 2:1 mixture of gelatin
and alginate to encapsulate epithelial progenitor cells of sweat
glands for bioprinting. Constructs containing cells alone or
added with epidermal growth factors (EGFs) and/or dermal
ECM were fabricated. The presence of dermal ECM was shown
to support cell differentiation, whereas the addition of both
dermal ECM and EGF resulted in functional regeneration of
sweat glands in the burned paws of mice. Interestingly, the same
group found that pore size of bioprinted constructs with the
same hydrogel composition had a remarkable influence on gland
self-organization and morphogenesis, with 300 μm pores
guiding in vitro organization.507
Salivary glands have also been looked at as a target for
bioprinting to aid in facilitating cell spatial organization. Adine et
al.508 used a magnetic bioprinter to steer the self-assembly of
stem cells derived from dental pulp through magnetic
nanoparticles and without the use of any hydrogels for cell
encapsulation. Cell spheroids were then differentiated into
salivary gland epithelial cells and assessed in an ex vivo
transplanted tissue model. Biological constructs showed the
presence of a neuronal cell subpopulation, which was important
for the reinnervation, a critical process in the correct function of
salivary glands. Furthermore, secretion of α-amylase, an enzyme
produced during salivary gland function, was also successfully
monitored.
A final example of gland bioprinting was reported by Bulanova
et al.509 for the thyroid, an organ responsible for the regulation of
hormone synthesis essential for growth, neurological develop-
ment, and homeostasis. Spheroids of embryonic thyroid and
ECs were formed and bioprinted adjacent to each other on a
collagen substrate. The spheroids fused, forming a vascularized
thyroid construct that restored thyroid activity in a hypothyroid
mouse model. These few successful reports demonstrate that
bioprinting is a promising technology to fabricate biologically
functional gland constructs and could spur further applications
for other gland tissues.
8.2. Cornea
The cornea is responsible for ∼80% of the refractive power of
the whole eye. It has a particular collagen fiber orientation,
forming between 200 and 250 lamellae that are responsible for
the tissue strength and spherical geometry. Collagen lamellae are
aligned in the mid and posterior parts and interwoven in the
anterior part of the tissue. This particular alignment is also
responsible for the transmission and refraction of light
subsequently focused onto the retina. Considering this
particular organization, current TERM approaches have proven
to be challenging. Therefore, bioprinting has been studied in
view of the possibility to recreate such a microstructural ECM
architecture. In a proof-of-concept study, Wu et al.510
encapsulated human corneal epithelial cells into an alginate/
gelatin/collagen hydrogel mixture, showing that cells survived
the bioprinting process. As the hydrogel degraded, cells were
able to remodel it during culture, enhanced their proliferation,
and expressed higher content of cytokeratin 3, a specific protein
of corneal ECM. The fabricated constructs had a classical
squared pore grid, which is far from the native organization of
corneal collagen fibers. Isaacson et al.511 recently showed that
collagen/alginate mixtures at different collagen concentrations
(6 mg/mL and 8 mg/mL) and ratios (2:1 or 3:1) could be used
to bioprint corneal keratinocytes into anatomically shaped
corneal constructs through the interpolation of clinical data sets.
The resulting construct maintained the anatomical shape during
culture, where higher collagen concentrations and the 3:1
collagen/alginate ratio resulted in higher resolution. Further
studies of this promising approach should aim at assessing
functional markers in vitro and in vivo. The most promising
bioprinted corneal construct fabricated to date was reported by
Sorkio et al.,164 who used laser-assisted bioprinting to deposit
both the epithelial and the stromal compartments of the cornea.
For the epithelial layer, limbal epithelial stem cells derived from
ESCs were used and encapsulated in human recombinant
laminin-521 for bioprinting. For the stromal layer, human
adipose tissue-derived stem cells were used and encapsulated in
human collagen type I for bioprinting. The two layers were
separated by an acellular compartment bioprinted from a
mixture of collagen, human plasma, thrombin, and HA. The
resulting construct showed stratification on the epithelial side,
which was also positive for cytokeratin-3 on the apical side and
for progenitor markers like p40 and p63α; the stromal side
showed similar cell alignment and organization compared to
native cornea. The construct integrated well in a porcine corneal
organ culture model, yet in vivo studies are needed to further
validate this approach.
In addition to the cornea, bioprinting of retinal ganglion cells
and glia,28 as well as of retinal pigment epithelial cell lines,512 has
been successfully reported. In both studies, cells were bioprinted
without the use of carrying hydrogels, which will be needed
when more complex eye tissues, such as frontal cornea and the
retina, are constructed.
8.3. Muscle
Patients that undergo muscular trauma or tumor ablation might
lose large portions of tissue, and alternatives to transplantation
are required. The bioprinting community has started to
investigate the possibility to replicate the highly aligned ECM
architecture of the muscle tissue while ensuring anisotropic
properties. Garcia-Lizarribar et al.513 screened different blends
of GelMA with methacrylated alginate or carboxymethyl
cellulose (CMC) or with PEGDA. Mixtures with alginate and
CMC resulted in durable bioprinted constructs and maintained
cell viability and myotube formation, which is a classic marker
for myocyte differentiation. Similar results have been obtained
by Mozetic et al.514 using Pluronic and assessing myocyte
differentiation by gene expression of a panel of myocyte
differentiation markers. Costantini et al.45 moved beyond these
initial studies by using coaxial microfluidic bioprinting where
alginate was used as a sacrificial bioink to build softer regions
within a PEG-fibrinogen hydrogel containing myoblasts. The
aligned constructs resulted in myoblast differentiation assessed
both at a genetic and at a protein level with a parallel
organization. In addition, these constructs were successfully
engrafted in vivo, maintaining myocyte phenotype. A further
improvement in muscle bioprinting has been demonstrated by
Choi et al.,71 who used dECM from porcine skeletal muscle to
create a gel-like formulation where myocytes were embedded
and bioprinted in between the fibers of a PCL scaffold acting as a
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mechanical stabilizer. The resulting biological constructs were
not only positive for muscle markers as assessed at a genetic and
protein level but also supported significantly longer myocyte
alignment and increased mechanical properties compared to
collagen. To further replicate the hierarchical structure of
muscle, Yeo et al.515 developed a construct by combining AM,
electrospinning, and bioprinting that once wrapped could form a
cylindrical scaffold. PCLwas used for AM and electrospinning to
create a scaffold with macro- and nanofibers, where the
macrofibers had a more mechanically supportive role and the
nanofibers further guidedmyocyte alignment after bioprinting in
an alginate/PEG bioink. These constructs again were shown to
support myocyte adhesion, proliferation, and differentiation.
Despite all these approaches demonstrating successful
myocyte differentiation, they used already differentiated
myocytes, typically from an animal cell line, which are less
relevant for clinical translation. In an attempt to get close to
clinically relevant biological constructs, Kim et al.516 used
human muscle progenitor cells encapsulated in a mixture of
gelatin, HA, and fibrinogen in glycerol. The cell-laden bioink was
bioprinted between PCL AM fibers acting as a mechanical
support, as previously described in other studies. High density
constructs supported cell alignment and differentiation and
showed vascular and neural integration in vivo and a recovery of
up to 82% of the muscular force of contraction of the native
muscle. The same group previously demonstrated that these
kinds of biological bioprinted constructs could be produced with
human scaled dimensions, although further preclinical studies in
larger animal models are needed before starting translation into
clinics.377
Bioprinting of the muscle−tendon interface tissue also has
been attempted. Merceron et al.75 used again a mixture of
gelatin, HA, and fibrinogen to encapsulate myocytes and
fibroblasts for muscle and tendon tissues, respectively. The
bioink was coprinted in between polyurethane fibers for the
muscle side and PCL fibers for the tendon side. Instead of
contiguous variation from the muscle to tendon, Laternser et
al.517 preferred to bioprint myocytes and tenocytes in alternating
layers. GelMA alone or in combination with PEGDMAwas used
as the hydrogel, without the use of other mechanically
supporting thermoplastic polymers. In both studies, in vitro
evaluation showed the support of muscle−tendon tissue
regeneration, thus suggesting that bioprinting could be a
promising tool for the regeneration of this composite interface
tissue.
8.4. Reproductive System
Bioprinting of constructs for the reproductive system has been
limited to a few studies. Laronda et al.518 showed that ovarian
follicle viability and functionality were significantly influenced
by gelatin scaffold pore geometry, with 30° and 60° providing a
better nesting environment. This resulted in the exciting
recovery of fertility in a sterilized mouse model and the
subsequent healthy survival of newborn pups. While only this
one study shows the promise of biofabrication approaches for
the reproductive system, we think that this should be a field of
application where more and more research should be conducted
because organs of the reproductive system are particularly
susceptible to environmental variations, such as radiation, and
could benefit from bioprinting approaches.
9. CONCLUSIONS AND FUTURE OUTLOOK
Since the first experiments of cell bioprinting were successfully
demonstrated in 2003,26 many advances have been made. While
many tissues or organ units have been envisioned and
manufactured, the level of complexity needed to make relevant
tissue and organ replacements is still not understood.
Several questions remain open when approaching complex
regeneration strategies as in the case of organs. These biological
systems are comprised of multiple tissues intimately connected
to each other, and multiple cell types direct tissue development
and homeostasis. We do not know what level of biomimicry of
the native tissue or organ is needed: do we need to copy the
whole organ structure, or can we achieve functional recovery
with a tissue patch that is implanted in the damaged organ? In
addition to the level of biomimicry, we also do not know if we
need to use all the cellular subpopulations of if we could achieve
differentiation into the needed phenotypes from a single-cell
population such as PSCs. Can bioprinting make use of organoid
technology to achieve more complex organ regeneration?
Bioprinting technology would have to be sufficiently equipped
to answer these questions, where multimaterial depositing
systems can recreate the intrinsic heterogeneity of more complex
structures.86,519 Furthermore, comparative studies will be
important to assess whether the biomimicry level that
bioprinting can achieve is sufficient compared to other
strategies, such as upscaling organoid production for further
cell-therapy-based implantation,520−522 where biomimicry is
limited and left to cellular self-assembly, or decellularized organs
from human donors or other species,523−525 where the most
exquisite degree of biomimicry would be achieved.
In the context of biomimetic and complex tissues, bioprinting
could offer an exciting technology platform to incorporate
lympathic, vascular, and neural networks, thus capturing the
complexity of multiple tissue and organ systems. In this respect,
biomaterials able to modulate the innate immune re-
sponse526,527 may also be good candidates for bioprinting.526,527
The ultimate exploitation of the true potential of the different
bioprinting technologies will be gradually proven as new
biomaterials and suitable cells are selected to efficiently be
used as regenerative medicine therapies for tissues and
eventually as a suitable replacement for organs. Despite these
ambitious aims, the complexity is enormous, and much more
studies are necessary to achieve these goals. In the short run, the
tissue and organ models are slowly being adopted as alternative
3D screening models for the cosmetic and pharmaceutical
industries. In parallel, as an astounding amount of data is being
generated in the pursuit of optimal cell−biomaterial interactions
for the regeneration of targeted tissues and from the use of such
3D screening models for cosmetic and pharmaceutical
applications, we advocate for the use of advanced bioinformatics
tools like artificial intelligence. This will allow us to navigate
through the big data generated by bioprinting in a more rational
manner, which will enable us to better streamline the
manufacturing processes to get step-by-step closer to multitissue
regeneration. Ultimately, we also advocate for the integration of
multiple technologies in an automated fashion, to cover the
biofabrication line from production and maturation to quality
assessment of the bioprinted constructs. To achieve this, the
assembly of a bioprinting station for production, followed by
bioreactor technology for biological maturation and advanced
imaging for quality assessment, could be envisioned. Such an
automated integrated bioprocessing line would ensure a faster
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translation from the academia to the industry through the
implementation of several standard operating procedures that
are direly needed to pass through the approval of regulatory
bodies.
AUTHOR INFORMATION
Corresponding Authors
Lorenzo Moroni − Department of Complex Tissue Regeneration,
MERLN Institute for Technology-Inspired Regenerative Medicine,
Maastricht University, 6211 LK Maastricht, The Netherlands;
orcid.org/0000-0003-1298-6025; Email: l.moroni@
maastrichtuniversity.nl
Carlos Mota − Department of Complex Tissue Regeneration,
MERLN Institute for Technology-Inspired Regenerative Medicine,
Maastricht University, 6211 LK Maastricht, The Netherlands;
orcid.org/0000-0001-5935-6245; Email: c.mota@
maastrichtuniversity.nl
Authors
Sandra Camarero-Espinosa − Department of Complex Tissue
Regeneration, MERLN Institute for Technology-Inspired
Regenerative Medicine, Maastricht University, 6211 LK
Maastricht, The Netherlands; orcid.org/0000-0003-0414-
7141
Matthew B. Baker − Department of Complex Tissue
Regeneration, MERLN Institute for Technology-Inspired
Regenerative Medicine, Maastricht University, 6211 LK
Maastricht, The Netherlands; orcid.org/0000-0003-1731-
3858
Paul Wieringa − Department of Complex Tissue Regeneration,
MERLN Institute for Technology-Inspired Regenerative
Medicine, Maastricht University, 6211 LK Maastricht, The
Netherlands; orcid.org/0000-0002-3290-5125
Complete contact information is available at:
https://pubs.acs.org/10.1021/acs.chemrev.9b00789
Notes
The authors declare no competing financial interest.
Biographies
Dr. Carlos Mota is an Assistant Professor in the Department of
Complex Tissue Regeneration, MERLN Institute for Technology-
inspired Regenerative Medicine, Maastricht University, The Nether-
lands. Dr. Mota received his PhD in Biomaterials from the BIOS
research doctorate school in Biomolecular Sciences at the University of
Pisa, Italy, in March 2012. Currently, his main research interests focus
on biofabrication, bioprinting, and additive manufacturing techniques
for the development of tissue-engineered constructs.
Dr. Sandra Camarero-Espinosa developed her doctoral studies at the
Adolphe Merkle Institute (Switzerland) and obtained her PhD degree
in Polymer Chemistry and Bioengineering in 2015. After gaining a
fellowship from the Swiss National Science Foundation, she moved to
Brisbane (Australia) to work at the Australian Institute for
Bioengineering and Nanotechnology. Sandra is now a postdoctoral
researcher at the MERLN Institute where she works on the
development of instructive biomaterial scaffolds for the regeneration
of complex tissues.
Dr.Matthew Baker received his B.S. in chemistry at ClemsonUniversity
(2006) and his PhD in Physical Organic Chemistry at the University of
Florida (2012). After his PhD, he pursued a postdoctoral study at the
Eindhoven University of Technology to design and characterize water-
soluble supramolecular polymers. In 2015, he joined the MERLN
Institute at Maastricht University to develop polymeric and supra-
molecular materials for tissue engineering and started the BioMatt
group as an Assistant Professor in 2017. His research interests include
the synthesis and characterization of novel and dynamic materials to
mimic the cellular environment and to influence cellular behavior.
Dr. PaulWieringa completed a dual PhD in 2014 from the University of
Twente (NL) and Scuola Superiore Sant’Anna (IT) on 3D electrospun
scaffolds for nerve regeneration. After his postdoctoral fellow at the
MERLN Institute from 2014 to 2017, he became an Assistant Professor
in 2018 atMERLN and is currently leading a research group on creating
3D in vitro models of tissue innervation to explore neurogenic tissue
repair strategies.
Prof. Lorenzo Moroni received his PhD cum laude in 2006 from
Twente University on 3D scaffolds for osteochondral regeneration.
Since 2014, he has worked at Maastricht University, as a founding
member of the MERLN Institute for Technology-Inspired Regener-
ative Medicine. In 2016, he became Full Professor in biofabrication for
regenerative medicine. Since 2019, he has been chair of the Complex
Tissue Regeneration department and Vice Director of MERLN. His
research group aims at developing biofabrication technologies to
control cell fate, with applications spanning from skeletal to vascular,
neural, and organ regeneration. From his research efforts, three
products have already reached the market.
ACKNOWLEDGMENTS
We are grateful to the Dutch Kidney Foundation (Nierstichting
Nederland, grant 18OI17 − Innovation Call 2018) and to the
European Research Council starting grant “Cell Hybridge”
(Grant #637308) and H2020-NMP-PILOTS-2015 “FAST”
(Grant #685825), under the Horizon 2020 framework program
for financial support. We also acknowledge support from the
Dutch Province of Limburg and from the research programme
Innovation Fund Chemistry, which is partly financed by The
Netherlands Organisation for Scientific Research (NWO). The
authors would like to thank Rogier Trompert for the
illustrations.
REFERENCES
(1) Harrison, R. H.; St-Pierre, J. P.; Stevens, M.M. Tissue Engineering
and Regenerative Medicine: A Year in Review. Tissue Eng., Part B 2014,
20, 1.
(2) Gomes, M. E.; Rodrigues, M. T.; Domingues, R. M. A.; Reis, R. L.
Tissue Engineering and Regenerative Medicine: New Trends and
Directions-a Year in Review. Tissue Eng., Part B 2017, 23, 211.
(3) Langer, R.; Vacanti, J. P. Tissue Engineering. Science 1993, 260,
920.
(4) Place, E. S.; Evans, N. D.; Stevens, M. M. Complexity in
Biomaterials for Tissue Engineering. Nat. Mater. 2009, 8, 457.
(5) Lutolf, M. P.; Hubbell, J. A. Synthetic Biomaterials as Instructive
Extracellular Microenvironments for Morphogenesis in Tissue
Engineering. Nat. Biotechnol. 2005, 23, 47.
(6) Mano, J. F.; Silva, G. A.; Azevedo, H. S.; Malafaya, P. B.; Sousa, R.
A.; Silva, S. S.; Boesel, L. F.; Oliveira, J. M.; Santos, T. C.; Marques, A.
P.; et al. Natural Origin Biodegradable Systems in Tissue Engineering
and Regenerative Medicine: Present Status and Some Moving Trends.
J. R. Soc., Interface 2007, 4, 999.
(7) Slaughter, B. V.; Khurshid, S. S.; Fisher, O. Z.; Khademhosseini,
A.; Peppas, N. A. Hydrogels in Regenerative Medicine. Adv. Mater.
2009, 21, 3307.
(8) Caplan, A. I. Adult Mesenchymal Stem Cells for Tissue
Engineering Versus Regenerative Medicine. J. Cell. Physiol. 2007, 213,
341.
Chemical Reviews pubs.acs.org/CR Review
https://dx.doi.org/10.1021/acs.chemrev.9b00789
Chem. Rev. XXXX, XXX, XXX−XXX
AU
(9) Gimble, J. M.; Katz, A. J.; Bunnell, B. A. Adipose-Derived Stem
Cells for Regenerative Medicine. Circ. Res. 2007, 100, 1249.
(10) Robinton, D. A.; Daley, G. Q. The Promise of Induced
Pluripotent Stem Cells in Research and Therapy. Nature 2012, 481,
295.
(11)Groll, J.; Boland, T.; Blunk, T.; Burdick, J. A.; Cho, D.W.; Dalton,
P. D.; Derby, B.; Forgacs, G.; Li, Q.; Mironov, V. A.; et al.
Biofabrication: Reappraising the Definition of an Evolving Field.
Biofabrication 2016, 8, 013001.
(12) Mota, C.; Puppi, D.; Chiellini, F.; Chiellini, E. Additive
Manufacturing Techniques for the Production of Tissue Engineering
Constructs. J. Tissue Eng. Regener. Med. 2015, 9, 174.
(13) Ligon, S. C.; Liska, R.; Stampfl, J.; Gurr, M.; Mulhaupt, R.
Polymers for 3d Printing and Customized Additive Manufacturing.
Chem. Rev. 2017, 117, 10212.
(14) Murphy, S. V.; Atala, A. 3d Bioprinting of Tissues and Organs.
Nat. Biotechnol. 2014, 32, 773.
(15) Ozbolat, I. T.; Hospodiuk, M. Current Advances and Future
Perspectives in Extrusion-Based Bioprinting. Biomaterials 2016, 76,
321.
(16)Mandrycky, C.; Wang, Z.; Kim, K.; Kim, D. H. 3d Bioprinting for
Engineering Complex Tissues. Biotechnol. Adv. 2016, 34, 422.
(17) Holzl, K.; Lin, S.; Tytgat, L.; Van Vlierberghe, S.; Gu, L.;
Ovsianikov, A. Bioink Properties before, During and after 3d
Bioprinting. Biofabrication 2016, 8, 032002.
(18) Gudapati, H.; Dey, M.; Ozbolat, I. A Comprehensive Review on
Droplet-Based Bioprinting: Past, Present and Future. Biomaterials
2016, 102, 20.
(19) Zhang, Y. S.; Yue, K.; Aleman, J.; Mollazadeh-Moghaddam, K.;
Bakht, S. M.; Yang, J.; Jia, W.; Dell’Erba, V.; Assawes, P.; Shin, S. R.;
Dokmeci, M. R.; Oklu, R.; Khademhosseini, A.; et al. 3d Bioprinting for
Tissue and Organ Fabrication. Ann. Biomed. Eng. 2017, 45, 148.
(20) Gao, B.; Yang, Q.; Zhao, X.; Jin, G.; Ma, Y.; Xu, F. 4d Bioprinting
for Biomedical Applications. Trends Biotechnol. 2016, 34, 746.
(21) Tomasina, C.; Bodet, T.; Mota, C.; Moroni, L.; Camarero-
Espinosa, S. Bioprinting Vasculature: Materials, Cells and Emergent
Techniques. Materials 2019, 12, 2701.
(22) Pereira, F. D. A. S.; Parfenov, V.; Khesuani, Y. D.; Ovsianikov, A.;
Mironov, V. In 3d Printing and Biofabrication; Ovsianikov, A., Yoo, J.,
Mironov, V., Eds.; Springer International Publishing: Cham, 2018.
(23) Choudhury, D.; Anand, S.; Naing, M. W. The Arrival of
Commercial Bioprinters - Towards 3d Bioprinting Revolution! Int. J.
Bioprinting 2018, DOI: 10.18063/ijb.v4i2.139.
(24) Mota, C.; Moroni, L. High Throughput Screening With
biofabrication Platforms; Academic Press: Boston, 2015.
(25) Cui, X.; Boland, T. Human Microvasculature Fabrication Using
Thermal Inkjet Printing Technology. Biomaterials 2009, 30, 6221.
(26) Wilson, W. C., Jr.; Boland, T. Cell and Organ Printing 1: Protein
and Cell Printers. Anat. Rec. 2003, 272, 491.
(27) Saunders, R. E.; Gough, J. E.; Derby, B. Delivery of Human
Fibroblast Cells by Piezoelectric Drop-on-Demand Inkjet Printing.
Biomaterials 2008, 29, 193.
(28) Lorber, B.; Hsiao, W. K.; Hutchings, I. M.; Martin, K. R. Adult
Rat Retinal Ganglion Cells and Glia Can Be Printed by Piezoelectric
Inkjet Printing. Biofabrication 2014, 6, 015001.
(29) Demirci, U.; Montesano, G. Single Cell Epitaxy by Acoustic
Picolitre Droplets. Lab Chip 2007, 7, 1139.
(30) Guo, F.; Mao, Z.; Chen, Y.; Xie, Z.; Lata, J. P.; Li, P.; Ren, L.; Liu,
J.; Yang, J.; Dao, M.; et al. Three-Dimensional Manipulation of Single
Cells Using Surface Acoustic Waves. Proc. Natl. Acad. Sci. U. S. A. 2016,
113, 1522.
(31) Parfenov, V. A.; Koudan, E. V.; Bulanova, E. A.; Karalkin, P. A.;
Das Pereira, F.; Norkin, N. E.; Knyazeva, A. D.; Gryadunova, A. A.;
Petrov, O. F.; Vasiliev, M. M.; et al. Scaffold-Free, Label-Free and
Nozzle-Free Biofabrication Technology Using Magnetic Levitational
Assembly. Biofabrication 2018, 10, 034104.
(32) Durmus, N. G.; Tekin, H. C.; Guven, S.; Sridhar, K.; Arslan
Yildiz, A.; Calibasi, G.; Ghiran, I.; Davis, R. W.; Steinmetz, L. M.;
Demirci, U. Magnetic Levitation of Single Cells. Proc. Natl. Acad. Sci. U.
S. A. 2015, 112, No. E3661.
(33) Marycz, K.; Kornicka, K.; Rocken, M. Static Magnetic Field
(Smf) as a Regulator of Stem Cell Fate - New Perspectives in
RegenerativeMedicine Arising from anUnderestimated Tool. StemCell
Rev. Rep. 2018, 14, 785.
(34) Ma, X.; Qu, X.; Zhu, W.; Li, Y. S.; Yuan, S.; Zhang, H.; Liu, J.;
Wang, P.; Lai, C. S.; Zanella, F.; et al. Deterministically Patterned
Biomimetic Human Ipsc-Derived Hepatic Model Via Rapid 3d
Bioprinting. Proc. Natl. Acad. Sci. U. S. A. 2016, 113, 2206.
(35) Ooi, H. W.; Mota, C.; Ten Cate, A. T.; Calore, A.; Moroni, L.;
Baker, M. B. Thiol-Ene Alginate Hydrogels as Versatile Bioinks for
Bioprinting. Biomacromolecules 2018, 19, 3390.
(36) Michael, S.; Sorg, H.; Peck, C. T.; Koch, L.; Deiwick, A.;
Chichkov, B.; Vogt, P. M.; Reimers, K. Tissue Engineered Skin
Substitutes Created by Laser-Assisted Bioprinting Form Skin-Like
Structures in the Dorsal Skin Fold Chamber inMice. PLoS One 2013, 8,
No. e57741.
(37) Xing, J. F.; Zheng, M. L.; Duan, X. M. Two-Photon
Polymerization Microfabrication of Hydrogels: An Advanced 3d
Printing Technology for Tissue Engineering and Drug Delivery.
Chem. Soc. Rev. 2015, 44, 5031.
(38) Dobos, A.; Van Hoorick, J.; Steiger, W.; Gruber, P.; Markovic,
M.; Andriotis, O. G.; Rohatschek, A.; Dubruel, P.; Thurner, P. J.; Van
Vlierberghe, S.; Baudis, S.; Ovsianikov, A.; et al. Thiol-Gelatin-
Norbornene Bioink for Laser-Based High-Definition Bioprinting.
Adv. Healthcare Mater. 2019, 1900752.
(39) Bernal, P. N.; Delrot, P.; Loterie, D.; Li, Y.; Malda, J.; Moser, C.;
Levato, R. Volumetric Bioprinting of Complex Living-Tissue
Constructs within Seconds. Adv. Mater. 2019, 31, No. e1904209.
(40) Kelly, B. E.; Bhattacharya, I.; Heidari, H.; Shusteff, M.;
Spadaccini, C. M.; Taylor, H. K. Volumetric Additive Manufacturing
Via Tomographic Reconstruction. Science 2019, 363, 1075.
(41) Mark, D.; Haeberle, S.; Roth, G.; von Stetten, F.; Zengerle, R.
Microfluidic Lab-on-a-Chip Platforms: Requirements, Characteristics
and Applications. Chem. Soc. Rev. 2010, 39, 1153.
(42) Whitesides, G. M. The Origins and the Future of Microfluidics.
Nature 2006, 442, 368.
(43) Barata, D.; van Blitterswijk, C.; Habibovic, P. High-Throughput
Screening Approaches and Combinatorial Development of Biomate-
rials Using Microfluidics. Acta Biomater. 2016, 34, 1.
(44) Colosi, C.; Shin, S. R.; Manoharan, V.; Massa, S.; Costantini, M.;
Barbetta, A.; Dokmeci, M. R.; Dentini, M.; Khademhosseini, A.
Microfluidic Bioprinting of Heterogeneous 3d Tissue Constructs Using
Low-Viscosity Bioink. Adv. Mater. 2016, 28, 677.
(45) Costantini, M.; Testa, S.; Mozetic, P.; Barbetta, A.; Fuoco, C.;
Fornetti, E.; Tamiro, F.; Bernardini, S.; Jaroszewicz, J.; Swieszkowski,
W.; et al. Microfluidic-Enhanced 3d Bioprinting of Aligned Myoblast-
Laden Hydrogels Leads to Functionally Organized Myofibers in Vitro
and in Vivo. Biomaterials 2017, 131, 98.
(46) Snyder, J.; Son, A. R.; Hamid, Q.; Wu, H.; Sun, W. Hetero-
Cellular Prototyping by Synchronized Multi-Material Bioprinting for
Rotary Cell Culture System. Biofabrication 2016, 8, 015002.
(47) Zhao, H.; Chen, Y.; Shao, L.; Xie, M.; Nie, J.; Qiu, J.; Zhao, P.;
Ramezani, H.; Fu, J.; Ouyang, H.; et al. Airflow-Assisted 3d Bioprinting
of Human Heterogeneous Microspheroidal Organoids with Micro-
fluidic Nozzle. Small 2018, 14, No. e1802630.
(48) Abelseth, E.; Abelseth, L.; De la Vega, L.; Beyer, S. T.;
Wadsworth, S. J.; Willerth, S. M. 3d Printing of Neural Tissues Derived
from Human Induced Pluripotent Stem Cells Using a Fibrin-Based
Bioink. ACS Biomater. Sci. Eng. 2019, 5, 234.
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